| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphopyruvate hydratase activity | 1.11e-05 | 4 | 283 | 3 | GO:0004634 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 9.45e-05 | 129 | 283 | 9 | GO:0035591 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D19 MYCBP2 RAP1GAP2 GDI2 NF1 RAPGEF3 SRGAP3 EIF2B3 ARHGAP21 SH3BP5 DENND5B RAP1GDS1 IPO7 RASA2 CCDC88C RGS14 ARHGEF40 DOCK7 AGAP9 | 1.23e-04 | 507 | 283 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D19 MYCBP2 RAP1GAP2 GDI2 NF1 RAPGEF3 SRGAP3 EIF2B3 ARHGAP21 SH3BP5 DENND5B RAP1GDS1 IPO7 RASA2 CCDC88C RGS14 ARHGEF40 DOCK7 AGAP9 | 1.23e-04 | 507 | 283 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | PDE2A SUCLG2 GDI2 RND1 GVINP1 ERAS ANXA6 LRRK1 GTPBP10 ATL1 RGS14 RAB34 PDE5A RND2 AGAP9 RAB21 NIN | 1.89e-04 | 439 | 283 | 17 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | PDE2A SUCLG2 GDI2 RND1 GVINP1 ERAS ANXA6 LRRK1 GTPBP10 ATL1 RGS14 RAB34 PDE5A RND2 AGAP9 RAB21 NIN | 1.89e-04 | 439 | 283 | 17 | GO:0019001 |
| GeneOntologyMolecularFunction | interleukin-5 receptor binding | 2.00e-04 | 2 | 283 | 2 | GO:0005137 | |
| GeneOntologyMolecularFunction | magnesium ion binding | PDE2A TSSK2 SUCLG2 MAP3K7 POLR1A IDH1 ATP9A GTPBP10 ENO1 MAP2K7 ENO2 ENO3 | 2.23e-04 | 247 | 283 | 12 | GO:0000287 |
| GeneOntologyBiologicalProcess | intracellular transport | TPR SMG1 AUP1 MPDZ FYCO1 COG3 ERLEC1 SPTBN5 KPNA7 TLK1 ZC3H11A C17orf75 NF1 DST RAPGEF3 BAIAP3 ARHGAP21 PLEKHA8 WWC1 SFN KPNA4 HDAC6 IPO8 IPO7 RPAIN SYNE1 ATP9A SARNP RUFY1 EPG5 GRIP1 PIKFYVE CCDC88C TARDBP RGS14 RAB34 BBS7 GCC2 DOCK7 APPL1 CEP131 LRBA TBC1D23 RAB21 MAP2K1 HTT | 1.47e-07 | 1496 | 280 | 46 | GO:0046907 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | EPHB2 MYCBP2 INS RAP1GAP2 PTK6 FZD4 CFLAR NF1 ZNF296 NRXN1 PLXNB3 ACSL6 DIP2B HDAC6 SYNE1 FAT3 DDR2 GRIP1 LZTS1 FBXO31 MACF1 RND2 RAB21 MAP2K1 CUX1 NIN | 3.09e-07 | 612 | 280 | 26 | GO:0010975 |
| GeneOntologyBiologicalProcess | neuron projection development | SLC25A46 EPHB2 MYCBP2 INS UNC5B RAP1GAP2 MPDZ PTK6 FZD4 CFLAR NF1 DST ZNF296 NRXN1 PLXNB3 ACSL6 DIP2B HSPG2 KLHL1 HDAC6 SYNE1 FAT3 DDR2 LAMB1 ATP9A ATL1 WDR47 GRIP1 ARHGEF40 LZTS1 FBXO31 DOCK7 MACF1 RND2 ATOH1 TBC1D23 RAB21 MAP2K1 CUX1 NIN | 7.87e-07 | 1285 | 280 | 40 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SLC25A46 EPHB2 MYCBP2 UNC5B FZD4 DST NRXN1 PLXNB3 DIP2B HSPG2 HDAC6 SYNE1 FAT3 LAMB1 ATL1 WDR47 GRIP1 ARHGEF40 LZTS1 FBXO31 DOCK7 MACF1 RND2 ATOH1 RAB21 MAP2K1 CUX1 NIN | 1.34e-06 | 748 | 280 | 28 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TBC1D19 EPHB2 MYCBP2 INS SDCCAG8 RAP1GAP2 GDI2 PTK6 FZD4 CFLAR NF1 ZNF296 NRXN1 PLXNB3 ACSL6 DIP2B HDAC6 SYNE1 FAT3 DDR2 GRIP1 LZTS1 FBXO31 MACF1 RND2 RAB21 MAP2K1 CUX1 HTT NIN | 1.67e-06 | 846 | 280 | 30 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TBC1D19 EPHB2 MYCBP2 INS SDCCAG8 RAP1GAP2 GDI2 PTK6 FZD4 CFLAR NF1 ZNF296 NRXN1 PLXNB3 ACSL6 DIP2B HDAC6 SYNE1 FAT3 DDR2 GRIP1 LZTS1 FBXO31 MACF1 RND2 RAB21 MAP2K1 CUX1 HTT NIN | 2.49e-06 | 863 | 280 | 30 | GO:0031344 |
| GeneOntologyBiologicalProcess | neuron development | SLC25A46 EPHB2 MYCBP2 INS UNC5B RAP1GAP2 MPDZ PTK6 FZD4 CFLAR RND1 NF1 DST ZNF296 NRXN1 PLXNB3 ACSL6 DIP2B HSPG2 KLHL1 HDAC6 SYNE1 FAT3 DDR2 LAMB1 ATP9A ATL1 WDR47 GRIP1 ARHGEF40 LZTS1 FBXO31 DOCK7 MACF1 RND2 ATOH1 TBC1D23 RAB21 MAP2K1 CUX1 HTT NIN | 3.24e-06 | 1463 | 280 | 42 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SLC25A46 EPHB2 MYCBP2 UNC5B FZD4 DST NRXN1 PLXNB3 DIP2B HSPG2 HDAC6 SYNE1 LAMB1 ATP9A ATL1 WDR47 GRIP1 ARHGEF40 LZTS1 FBXO31 DOCK7 MACF1 RND2 ATOH1 RAB21 MAP2K1 CUX1 NIN | 5.07e-06 | 802 | 280 | 28 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of dendrite development | EPHB2 FZD4 ZNF296 HDAC6 SYNE1 FAT3 GRIP1 LZTS1 FBXO31 RAB21 CUX1 | 6.66e-06 | 150 | 280 | 11 | GO:0050773 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SLC25A46 EPHB2 MYCBP2 UNC5B FZD4 DST NRXN1 PLXNB3 DIP2B HSPG2 HDAC6 SYNE1 LAMB1 ATP9A ATL1 WDR47 GRIP1 ARHGEF40 LZTS1 FBXO31 DOCK7 MACF1 RND2 ATOH1 RAB21 MAP2K1 CUX1 NIN | 7.49e-06 | 819 | 280 | 28 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SLC25A46 EPHB2 MYCBP2 UNC5B FZD4 DST NRXN1 PLXNB3 DIP2B HSPG2 HDAC6 SYNE1 LAMB1 ATP9A ATL1 WDR47 GRIP1 ARHGEF40 LZTS1 FBXO31 DOCK7 MACF1 RND2 ATOH1 RAB21 MAP2K1 CUX1 NIN | 8.77e-06 | 826 | 280 | 28 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 1.13e-05 | 103 | 280 | 9 | GO:0048814 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TBC1D19 EPHB2 TPR SMG1 PDE2A MYCBP2 CENPF INS SDCCAG8 MTSS1 TOGARAM1 FYCO1 GDI2 ANKRD53 SPTBN5 RND1 NRXN1 RAPGEF3 RAD1 SDCBP RAP1GDS1 HDAC6 NOL3 SYNE1 LMOD2 WDR47 PIKFYVE CCDC88C RNH1 ARID2 CEP70 FBXO43 KANK4 RND2 MAP2K1 MAP2K7 IL5 HTT | 1.37e-05 | 1342 | 280 | 38 | GO:0033043 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | EPHB2 INS PTK6 FZD4 CFLAR NF1 NRXN1 PLXNB3 ACSL6 HDAC6 DDR2 GRIP1 FBXO31 MACF1 RND2 RAB21 MAP2K1 CUX1 HTT NIN | 1.51e-05 | 494 | 280 | 20 | GO:0031346 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | EPHB2 TPR CENPF RAP1GAP2 GDI2 SPTBN5 CFLAR ZNF296 NRXN1 RAPGEF3 RAD1 FBXL2 MAP3K7 SDCBP PLXNB3 DIP2B TMEM182 HSPG2 HDAC6 NOL3 FAT3 AIDA LMOD2 WDR47 CCDC88C FBXO43 KANK4 APPL1 | 1.99e-05 | 864 | 280 | 28 | GO:0051129 |
| GeneOntologyBiologicalProcess | axonogenesis | SLC25A46 EPHB2 MYCBP2 UNC5B DST NRXN1 PLXNB3 DIP2B HSPG2 HDAC6 LAMB1 ATL1 WDR47 ARHGEF40 DOCK7 MACF1 RND2 ATOH1 RAB21 MAP2K1 NIN | 3.36e-05 | 566 | 280 | 21 | GO:0007409 |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 3.42e-05 | 67 | 280 | 7 | GO:0050775 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SLC25A46 EPHB2 MYCBP2 UNC5B FZD4 DST NRXN1 PLXNB3 DIP2B HSPG2 HDAC6 SYNE1 FAT3 ANXA7 SH3KBP1 LAMB1 ATP9A JMJD1C ATL1 WDR47 GRIP1 CCDC88C ARHGEF40 MYH14 LZTS1 FBXO31 DOCK7 MACF1 RND2 ATOH1 RAB21 MAP2K1 CUX1 NIN | 3.64e-05 | 1194 | 280 | 34 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 4.14e-05 | 69 | 280 | 7 | GO:0010770 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | EPHB2 TPR MYCBP2 INS GDI2 ERLEC1 NF1 NRXN1 RAPGEF3 TRIM50 BAIAP3 NOS2 WWC1 SFN RAP1GDS1 POLR1A HDAC6 IPO7 NOL3 ANXA7 TRIM68 ATP9A RFPL4AL1 GRIP1 TARDBP RAB34 CEP72 GCC2 APPL1 CEP131 SPIDR RAB21 MAP2K1 HTT | 4.90e-05 | 1212 | 280 | 34 | GO:0060341 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | TBC1D19 EPHB2 TPR MYCBP2 SDCCAG8 MTSS1 TOGARAM1 MDGA2 GDI2 ANKRD53 SPTBN5 NRXN1 RAPGEF3 SRGAP3 FBXL2 MAP3K7 SDCBP PLXNB3 HDAC6 NOL3 SYNE1 AIDA IGSF11 CLSTN1 LMOD2 PIKFYVE LZTS1 KANK4 MACF1 SPIDR PEAK1 IL5 HTT | 7.82e-05 | 1189 | 280 | 33 | GO:0044087 |
| GeneOntologyBiologicalProcess | regulation of protein localization | EPHB2 TPR MYCBP2 INS GDI2 ERLEC1 NF1 NRXN1 RAPGEF3 TRIM50 BAIAP3 NOS2 SFN RAP1GDS1 POLR1A HDAC6 IPO7 NOL3 ANXA7 TRIM68 RFPL4AL1 GRIP1 TARDBP RAB34 CEP72 GCC2 APPL1 CEP131 SPIDR MAP2K1 HTT | 7.99e-05 | 1087 | 280 | 31 | GO:0032880 |
| GeneOntologyBiologicalProcess | negative regulation of syncytium formation by plasma membrane fusion | 1.32e-04 | 8 | 280 | 3 | GO:0034242 | |
| GeneOntologyBiologicalProcess | negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway | 1.32e-04 | 8 | 280 | 3 | GO:1903298 | |
| GeneOntologyBiologicalProcess | regulation of guanylate cyclase activity | 1.32e-04 | 8 | 280 | 3 | GO:0031282 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | EPHB2 PDE8A INS FZD4 CFLAR KSR1 NF1 NRXN1 MAP3K7 BANK1 SDCBP WWC1 RAP1GDS1 DDR2 AIDA PRDX2 PPEF2 PRAMEF13 AKAP12 CCDC88C RGS14 PRAMEF14 PDE5A MAP2K1 MAP2K7 | 1.34e-04 | 815 | 280 | 25 | GO:0043408 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | TPR INS KPNA7 NF1 KPNA4 RAP1GDS1 POLR1A IPO8 IPO7 RPAIN SYNE1 PIKFYVE TARDBP APPL1 HTT | 1.38e-04 | 362 | 280 | 15 | GO:0034504 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | EPHB2 RAP1GAP2 GDI2 KSR1 RND1 NF1 RAPGEF3 SRGAP3 ERAS ARHGAP21 SDCBP RASA2 RUFY1 CCDC88C ARHGEF40 DOCK7 RND2 RAB21 MAP2K1 | 1.52e-04 | 538 | 280 | 19 | GO:0007264 |
| GeneOntologyBiologicalProcess | observational learning | 1.96e-04 | 9 | 280 | 3 | GO:0098597 | |
| GeneOntologyBiologicalProcess | regulation of hypoxia-induced intrinsic apoptotic signaling pathway | 1.96e-04 | 9 | 280 | 3 | GO:1903297 | |
| GeneOntologyBiologicalProcess | axon development | SLC25A46 EPHB2 MYCBP2 UNC5B DST NRXN1 PLXNB3 DIP2B HSPG2 HDAC6 LAMB1 ATL1 WDR47 ARHGEF40 DOCK7 MACF1 RND2 ATOH1 RAB21 MAP2K1 NIN | 1.97e-04 | 642 | 280 | 21 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of purine nucleotide biosynthetic process | 1.98e-04 | 40 | 280 | 5 | GO:1900371 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide biosynthetic process | 1.98e-04 | 40 | 280 | 5 | GO:0030808 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | SLC25A46 EPHB2 AUP1 ACAT2 INS FYCO1 SUCLG2 CYP2W1 IDNK SUPT5H FBXL2 MAP3K7 NOS2 CYP26B1 HDAC6 ANXA7 UBR4 ACAD10 TRIM68 IDH1 PRDX2 CUBN EPG5 RFPL4AL1 WDR47 PIKFYVE LZTS1 AASS PAH LRBA TRIM13 MAP2K1 HTT | 2.08e-04 | 1253 | 280 | 33 | GO:0044248 |
| GeneOntologyBiologicalProcess | dendrite development | SLC25A46 EPHB2 MPDZ FZD4 ZNF296 KLHL1 HDAC6 SYNE1 FAT3 GRIP1 LZTS1 FBXO31 RAB21 CUX1 | 2.11e-04 | 335 | 280 | 14 | GO:0016358 |
| GeneOntologyBiologicalProcess | nuclear transport | TPR SMG1 KPNA7 ZC3H11A NF1 RAPGEF3 SFN KPNA4 IPO8 IPO7 RPAIN SARNP TARDBP RGS14 APPL1 | 2.21e-04 | 378 | 280 | 15 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | TPR SMG1 KPNA7 ZC3H11A NF1 RAPGEF3 SFN KPNA4 IPO8 IPO7 RPAIN SARNP TARDBP RGS14 APPL1 | 2.21e-04 | 378 | 280 | 15 | GO:0006913 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | EPHB2 ERBB3 INS PTK6 FZD4 KSR1 NF1 NRXN1 RAPGEF3 HSD11B1 MAP3K7 NOS2 BANK1 SDCBP SFN SH3BP5 HDAC6 IPO7 DDR2 AIDA LRRK1 IDH1 PPEF2 CCDC88C TARDBP RGS14 GUCA1A GUCA1B DOCK7 PDE5A MAP2K1 ENO1 MAP2K7 IL5 HTT SMAD7 | 2.24e-04 | 1421 | 280 | 36 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | EPHB2 ERBB3 INS PTK6 FZD4 KSR1 NF1 NRXN1 RAPGEF3 HSD11B1 MAP3K7 NOS2 BANK1 SDCBP SFN SH3BP5 HDAC6 IPO7 DDR2 AIDA LRRK1 IDH1 PPEF2 CCDC88C TARDBP RGS14 GUCA1A GUCA1B DOCK7 PDE5A MAP2K1 ENO1 MAP2K7 IL5 HTT SMAD7 | 2.30e-04 | 1423 | 280 | 36 | GO:0051174 |
| GeneOntologyBiologicalProcess | microtubule-based process | TPR SDCCAG8 TOGARAM1 FYCO1 ANKRD53 SLC9C1 DST ARHGAP21 CCNL2 HDAC6 DNAH2 ODAD2 WDR47 CCDC88C RGS14 CEP72 VANGL1 GCC2 CEP70 DOCK7 MACF1 CCDC120 CEP131 CEP152 RAB21 MAP2K1 HTT DNAH11 NIN | 2.67e-04 | 1058 | 280 | 29 | GO:0007017 |
| GeneOntologyBiologicalProcess | positive regulation of purine nucleotide biosynthetic process | 3.36e-04 | 25 | 280 | 4 | GO:1900373 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide biosynthetic process | 3.36e-04 | 25 | 280 | 4 | GO:0030810 | |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 3.66e-04 | 128 | 280 | 8 | GO:0007265 | |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | FZD4 KSR1 NF1 NRXN1 MAP3K7 SFN IPO7 AIDA PPEF2 RGS14 PDE5A MAP2K1 MAP2K7 HTT | 4.12e-04 | 358 | 280 | 14 | GO:0071900 |
| GeneOntologyBiologicalProcess | MAPK cascade | EPHB2 PDE8A INS FZD4 CFLAR KSR1 PTPN7 NF1 NRXN1 MAP3K7 BANK1 SDCBP WWC1 RAP1GDS1 DDR2 AIDA PRDX2 PPEF2 PRAMEF13 AKAP12 CCDC88C RGS14 PRAMEF14 PDE5A MAP2K1 MAP2K7 | 4.16e-04 | 930 | 280 | 26 | GO:0000165 |
| GeneOntologyBiologicalProcess | Schwann cell development | 4.28e-04 | 47 | 280 | 5 | GO:0014044 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | TPR PDE2A FZD4 CFLAR NF1 CLCA1 NRXN1 RAD1 EIF2B3 RAD54B MAP3K7 NOS2 VCAM1 HSPG2 HDAC6 NOL3 RPAIN SYNE1 ANXA7 DDR2 FBXL17 BABAM2 AKAP12 WDR47 RGS14 GUCA1A GUCA1B STC2 TANC1 SPIDR MAP2K1 ENO1 MAP2K7 HTT | 4.36e-04 | 1361 | 280 | 34 | GO:0009628 |
| GeneOntologyBiologicalProcess | protein localization to organelle | TPR AUP1 INS COG3 GDI2 KPNA7 NF1 KPNA4 RAP1GDS1 POLR1A IPO8 IPO7 NOL3 RPAIN SYNE1 SH3KBP1 CUBN PIKFYVE TARDBP RAB34 CEP72 GCC2 MACF1 APPL1 CEP131 SPIDR MAP2K1 HTT DNAH11 | 4.41e-04 | 1091 | 280 | 29 | GO:0033365 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | EPHB2 TPR INS MTSS1 TOGARAM1 FYCO1 PTK6 ANKRD53 FZD4 CFLAR NF1 NRXN1 RAPGEF3 SDCBP PLXNB3 ACSL6 HDAC6 SYNE1 DDR2 CLSTN1 LMOD2 GRIP1 FBXO31 MACF1 APPL1 RND2 SPIDR RAB21 MAP2K1 MAP2K7 IL5 CUX1 HTT NIN | 4.65e-04 | 1366 | 280 | 34 | GO:0051130 |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to hypoxia | 4.97e-04 | 12 | 280 | 3 | GO:1990144 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | TPR AUP1 MPDZ COG3 ERLEC1 KPNA7 TLK1 C17orf75 NF1 RAPGEF3 SFN KPNA4 HDAC6 IPO8 IPO7 RPAIN GRIP1 TARDBP GCC2 APPL1 CEP131 RAB21 | 5.18e-04 | 740 | 280 | 22 | GO:0006886 |
| GeneOntologyBiologicalProcess | process utilizing autophagic mechanism | SLC25A46 EPHB2 AUP1 FYCO1 SUPT5H FBXL2 MAP3K7 HDAC6 ANXA7 UBR4 TRIM68 EPG5 RFPL4AL1 WDR47 PIKFYVE LZTS1 LRBA TRIM13 MAP2K1 HTT | 6.06e-04 | 650 | 280 | 20 | GO:0061919 |
| GeneOntologyBiologicalProcess | autophagy | SLC25A46 EPHB2 AUP1 FYCO1 SUPT5H FBXL2 MAP3K7 HDAC6 ANXA7 UBR4 TRIM68 EPG5 RFPL4AL1 WDR47 PIKFYVE LZTS1 LRBA TRIM13 MAP2K1 HTT | 6.06e-04 | 650 | 280 | 20 | GO:0006914 |
| GeneOntologyBiologicalProcess | positive regulation of autophagy | 6.14e-04 | 173 | 280 | 9 | GO:0010508 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | EPHB2 FZD4 NRXN1 PLXNB3 HDAC6 CLSTN1 GRIP1 RGS14 FBXO31 MACF1 RND2 RAB21 MAP2K1 CUX1 NIN | 6.33e-04 | 418 | 280 | 15 | GO:0051962 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | TPR TOGARAM1 ANKRD53 CCNL2 HDAC6 ODAD2 WDR47 CCDC88C CEP70 MACF1 CEP131 DNAH11 | 7.05e-04 | 293 | 280 | 12 | GO:0032886 |
| GeneOntologyBiologicalProcess | microtubule-based transport | FYCO1 DST ARHGAP21 HDAC6 CCDC88C VANGL1 CEP131 RAB21 MAP2K1 HTT DNAH11 | 7.18e-04 | 253 | 280 | 11 | GO:0099111 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | EPHB2 FZD4 NF1 PLXNB3 DIP2B HDAC6 GRIP1 RGS14 FBXO31 DOCK7 MACF1 RND2 ATOH1 RAB21 MAP2K1 CUX1 NIN | 7.19e-04 | 515 | 280 | 17 | GO:0050767 |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | EPHB2 INS PTK6 FZD4 KSR1 NF1 NRXN1 MAP3K7 SFN SH3BP5 IPO7 DDR2 AIDA PPEF2 RGS14 PDE5A MAP2K1 MAP2K7 HTT | 7.30e-04 | 611 | 280 | 19 | GO:0045859 |
| GeneOntologyCellularComponent | phosphopyruvate hydratase complex | 9.22e-06 | 4 | 278 | 3 | GO:0000015 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | PDE2A PDE8A CENPF RAP1GAP2 DST RAPGEF3 NOS2 BANK1 WWC1 HDAC6 RASA2 SYNE1 ANXA6 LAMB1 ABCC5 MYO1B TRIM68 ATP9A EPG5 GRIP1 PIKFYVE RAB34 STC2 UNC45B TRIM13 MAP2K1 HTT | 1.36e-04 | 934 | 278 | 27 | GO:0048471 |
| GeneOntologyCellularComponent | microtubule organizing center | CENPF SDCCAG8 TSSK2 RAP1GAP2 TOGARAM1 KLHL4 HDAC6 TTC28 UBR4 SPECC1 CCDC88C RGS14 RAB34 CEP72 BBS7 FBXO31 CEP70 ERCC6L2 CCDC120 CEP131 CEP152 NAA40 MAP2K1 HTT SMAD7 NIN | 2.53e-04 | 919 | 278 | 26 | GO:0005815 |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 2.61e-04 | 10 | 278 | 3 | GO:0042564 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | CENPF TOGARAM1 EFHB SPTBN5 DST HDAC6 DNAH2 ODAD2 BBS7 RAB21 MAP2K1 HTT DNAH11 | 3.48e-04 | 317 | 278 | 13 | GO:0032838 |
| GeneOntologyCellularComponent | axon | EPHB2 CNTNAP3B PDE2A MYCBP2 CNTNAP3 NF1 DST NRXN1 RAPGEF3 DIP2B HDAC6 PRSS12 ATL1 WDR47 GRIP1 MYH14 DOCK7 CCDC120 TANC1 RAB21 MAP2K1 ENO1 ENO2 HTT NIN | 3.77e-04 | 891 | 278 | 25 | GO:0030424 |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 4.68e-04 | 12 | 278 | 3 | GO:0031074 | |
| Domain | Quino_amine_DH_bsu | 5.91e-07 | 22 | 275 | 6 | IPR011044 | |
| Domain | ARM-like | SMG1 HGH1 TOGARAM1 KPNA7 NF1 MED12 KPNA4 RAP1GDS1 IPO8 IPO7 ODAD2 UNC45B ARID2 CEP70 LRBA HTT | 2.71e-06 | 270 | 275 | 16 | IPR011989 |
| Domain | Enolase | 3.16e-06 | 3 | 275 | 3 | IPR000941 | |
| Domain | ENOLASE | 3.16e-06 | 3 | 275 | 3 | PS00164 | |
| Domain | Enolase_N | 3.16e-06 | 3 | 275 | 3 | PF03952 | |
| Domain | Enolase_C | 3.16e-06 | 3 | 275 | 3 | IPR020810 | |
| Domain | Enolase_N | 3.16e-06 | 3 | 275 | 3 | IPR020811 | |
| Domain | Enolase_CS | 3.16e-06 | 3 | 275 | 3 | IPR020809 | |
| Domain | Enolase_C | 3.16e-06 | 3 | 275 | 3 | PF00113 | |
| Domain | Enolase_N | 3.16e-06 | 3 | 275 | 3 | SM01193 | |
| Domain | Enolase_C | 3.16e-06 | 3 | 275 | 3 | SM01192 | |
| Domain | ARM-type_fold | SMG1 HGH1 INTS1 TOGARAM1 KPNA7 NF1 KPNA4 MYBBP1A RAP1GDS1 IPO8 IPO7 UBR4 ODAD2 UNC45B ARID2 LRBA HTT | 1.22e-05 | 339 | 275 | 17 | IPR016024 |
| Domain | - | 1.25e-05 | 4 | 275 | 3 | 3.30.390.10 | |
| Domain | - | 1.25e-05 | 4 | 275 | 3 | 3.20.20.120 | |
| Domain | Enolase_C-like | 1.25e-05 | 4 | 275 | 3 | IPR029065 | |
| Domain | Enolase_N-like | 1.25e-05 | 4 | 275 | 3 | IPR029017 | |
| Domain | - | HGH1 TOGARAM1 KPNA7 NF1 MED12 KPNA4 RAP1GDS1 IPO8 IPO7 ODAD2 UNC45B LRBA HTT | 2.67e-05 | 222 | 275 | 13 | 1.25.10.10 |
| Domain | ConA-like_dom | CNTNAP3B CNTNAP3 MDGA2 NRXN1 TRIM50 HSPG2 FAT3 TRIM68 CLSTN1 TRIM10 RFPL4AL1 LRBA | 1.03e-04 | 219 | 275 | 12 | IPR013320 |
| Domain | DED_dom | 1.06e-04 | 7 | 275 | 3 | IPR001875 | |
| Domain | DED | 1.06e-04 | 7 | 275 | 3 | PS50168 | |
| Domain | DED | 1.06e-04 | 7 | 275 | 3 | SM00031 | |
| Domain | DED | 1.06e-04 | 7 | 275 | 3 | PF01335 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 1.50e-04 | 19 | 275 | 4 | IPR006553 | |
| Domain | LRR_CC | 1.50e-04 | 19 | 275 | 4 | SM00367 | |
| Domain | Med12 | 2.16e-04 | 2 | 275 | 2 | PF09497 | |
| Domain | Mediator_Med12_catenin-bd | 2.16e-04 | 2 | 275 | 2 | IPR021989 | |
| Domain | Med12-PQL | 2.16e-04 | 2 | 275 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 2.16e-04 | 2 | 275 | 2 | PF12145 | |
| Domain | Mediator_Med12 | 2.16e-04 | 2 | 275 | 2 | IPR019035 | |
| Domain | Med12 | 2.16e-04 | 2 | 275 | 2 | SM01281 | |
| Domain | Mediator_Med12_LCEWAV | 2.16e-04 | 2 | 275 | 2 | IPR021990 | |
| Domain | LAM_G_DOMAIN | 2.25e-04 | 38 | 275 | 5 | PS50025 | |
| Domain | FA58C_3 | 2.26e-04 | 21 | 275 | 4 | PS50022 | |
| Domain | FA58C | 2.26e-04 | 21 | 275 | 4 | SM00231 | |
| Domain | FA58C_1 | 2.26e-04 | 21 | 275 | 4 | PS01285 | |
| Domain | FA58C_2 | 2.26e-04 | 21 | 275 | 4 | PS01286 | |
| Domain | ARM | 2.88e-04 | 40 | 275 | 5 | SM00185 | |
| Domain | Laminin_G_2 | 2.88e-04 | 40 | 275 | 5 | PF02210 | |
| Domain | Spectrin | 3.27e-04 | 23 | 275 | 4 | PF00435 | |
| Domain | ACTININ_2 | 3.27e-04 | 23 | 275 | 4 | PS00020 | |
| Domain | ACTININ_1 | 3.27e-04 | 23 | 275 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.27e-04 | 23 | 275 | 4 | IPR001589 | |
| Domain | F5_F8_type_C | 3.87e-04 | 24 | 275 | 4 | PF00754 | |
| Domain | FA58C | 3.87e-04 | 24 | 275 | 4 | IPR000421 | |
| Domain | F-box-like | 4.53e-04 | 44 | 275 | 5 | PF12937 | |
| Domain | LamG | 4.53e-04 | 44 | 275 | 5 | SM00282 | |
| Domain | F-box | 4.54e-04 | 67 | 275 | 6 | PF00646 | |
| Domain | Galactose-bd-like | 4.78e-04 | 94 | 275 | 7 | IPR008979 | |
| Domain | Armadillo | 6.17e-04 | 47 | 275 | 5 | IPR000225 | |
| Domain | Cse1 | 6.42e-04 | 3 | 275 | 2 | PF08506 | |
| Domain | Cse1 | 6.42e-04 | 3 | 275 | 2 | IPR013713 | |
| Domain | ACT_dom | 6.42e-04 | 3 | 275 | 2 | IPR002912 | |
| Domain | ACT | 6.42e-04 | 3 | 275 | 2 | PS51671 | |
| Domain | ACT | 6.42e-04 | 3 | 275 | 2 | PF01842 | |
| Domain | FBOX | 6.68e-04 | 72 | 275 | 6 | PS50181 | |
| Domain | Spectrin_repeat | 8.17e-04 | 29 | 275 | 4 | IPR002017 | |
| Domain | F-box_dom | 8.30e-04 | 75 | 275 | 6 | IPR001810 | |
| Domain | FBOX | 9.85e-04 | 52 | 275 | 5 | SM00256 | |
| Domain | Arm | 1.06e-03 | 31 | 275 | 4 | PF00514 | |
| Domain | SPEC | 1.20e-03 | 32 | 275 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.20e-03 | 32 | 275 | 4 | IPR018159 | |
| Domain | ArAA_hydroxylase_Fe/CU_BS | 1.27e-03 | 4 | 275 | 2 | IPR018301 | |
| Domain | BH4_AAA_HYDROXYL_2 | 1.27e-03 | 4 | 275 | 2 | PS51410 | |
| Domain | Biopterin_H | 1.27e-03 | 4 | 275 | 2 | PF00351 | |
| Domain | - | 1.27e-03 | 4 | 275 | 2 | 1.10.800.10 | |
| Domain | ArAA_hydroxylase | 1.27e-03 | 4 | 275 | 2 | IPR001273 | |
| Domain | Tyrosine_3-monooxygenase-like | 1.27e-03 | 4 | 275 | 2 | IPR019773 | |
| Domain | Aromatic-AA_hydroxylase_C | 1.27e-03 | 4 | 275 | 2 | IPR019774 | |
| Domain | BH4_AAA_HYDROXYL_1 | 1.27e-03 | 4 | 275 | 2 | PS00367 | |
| Domain | EF-hand_7 | 1.60e-03 | 85 | 275 | 6 | PF13499 | |
| Domain | Laminin_G | 1.62e-03 | 58 | 275 | 5 | IPR001791 | |
| Domain | P-loop_NTPase | SLFN5 IDNK RND1 LRRIQ1 RAD54B ERAS DNAH2 ABCC5 ABCC11 MYO1B LRRK1 RFC1 TEP1 GTPBP10 ATL1 RAB34 SBNO1 MYH14 ERCC6L2 RND2 AGAP9 RAB21 SMC1B DNAH11 | 1.74e-03 | 848 | 275 | 24 | IPR027417 |
| Pubmed | TPR PDE2A MYCBP2 CENPF MCC MPDZ FYCO1 GDI2 NF1 DST NRXN1 SRGAP3 ZBTB21 ARHGAP21 SH3BP5 DIP2B MYBBP1A SYNE1 UBR4 SH3KBP1 PRDX2 AKAP12 WDR47 CCDC88C LZTS1 DOCK7 ANKRD17 MACF1 APPL1 CEP131 ENO1 CUX1 | 2.04e-11 | 963 | 283 | 32 | 28671696 | |
| Pubmed | SMG1 AUP1 PARP4 C17orf75 NF1 HERC6 WDR17 IPO7 RASA2 TTC28 ANXA6 UBR4 DNAH2 RFC1 LMOD2 BABAM2 LZTS1 CEP72 BBS7 AASS GCC2 ARID2 ANKRD17 RAB21 CUX1 DNAH11 | 2.23e-11 | 638 | 283 | 26 | 31182584 | |
| Pubmed | ERBB3 PDE2A MYCBP2 RAP1GAP2 UBA7 DST SUPT5H WDR17 SMURF2 ARHGAP21 SDCBP PLXNB3 SH3BP5 KLHL4 KPNA4 RAP1GDS1 HDAC6 TTC28 SYNE1 TAF1C ANXA7 UBR4 ADNP2 LAMB1 ABCC5 TRIM68 SPECC1 DALRD3 WDR47 SBNO1 MYH14 CEP70 MACF1 APPL1 LRBA TBC1D23 CUX1 | 3.07e-11 | 1285 | 283 | 37 | 35914814 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PDE2A MYCBP2 INTS1 RAP1GAP2 FYCO1 TLK1 ZC3H11A DST ZNF296 ZMIZ2 EIF2B3 ZNF398 SMURF2 ARHGAP21 MED12 ANKRD16 HSPG2 UBR4 FBXL14 LRRK1 TEP1 BABAM2 ANO8 PIKFYVE CCDC88C ARHGEF40 KCNK5 HMGXB3 CEP131 TANC1 LRBA HTT SMAD7 | 1.56e-10 | 1105 | 283 | 33 | 35748872 |
| Pubmed | TPR ZNF148 MYCBP2 CENPF DST ZMIZ2 ZBTB21 ARHGAP21 MED12 TTC28 UBR4 RUFY1 JMJD1C GCC2 DOCK7 ANKRD17 CEP131 CRYBG3 LRBA CUX1 | 3.15e-10 | 418 | 283 | 20 | 34709266 | |
| Pubmed | KANSL1L ZNF148 HGH1 PTK6 DST PGBD2 MYBBP1A SYNE1 UBR4 DNAH2 ABCC5 AKAP12 PIKFYVE TPH2 DNAH11 | 1.00e-09 | 233 | 283 | 15 | 37704626 | |
| Pubmed | TPR MYCBP2 CENPF INTS1 GDI2 ZC3H11A NF1 DST SUPT5H MED12 MYBBP1A POLR1A IPO7 ANXA6 UBR4 MYO1B RFC1 RNH1 MYH14 UTP4 DOCK7 ANKRD17 MACF1 SCAF11 | 1.07e-09 | 653 | 283 | 24 | 22586326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR MYCBP2 AUP1 ACAT2 PSMB2 SUCLG2 ZC3H11A NF1 DST EIF2B3 MED12 MYBBP1A POLR1A HDAC6 IPO7 DSC1 RASA2 TAF1C UBR4 ADNP2 MYO1B PRDX2 RFC1 SRBD1 WDR47 TARDBP ARHGEF40 RAB34 RNH1 MYH14 UTP4 ANKRD17 MACF1 TANC1 ENO1 | 1.85e-09 | 1353 | 283 | 35 | 29467282 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MYCBP2 TSSK2 MPDZ KSR1 NF1 DST ZBTB21 ARHGAP21 SFN DIP2B TTC28 TRIM68 SPECC1 GRIP1 CCDC88C AASS DOCK7 ANKRD17 MACF1 CEP131 CEP152 TANC1 CRYBG3 PEAK1 RAB21 MAP2K1 MAP2K7 | 2.88e-09 | 861 | 283 | 27 | 36931259 |
| Pubmed | TPR AUP1 UNC5B MPDZ DST ARHGAP21 MED12 MYBBP1A HDAC6 IPO7 TTC28 ABCC5 MYO1B JMJD1C AKAP12 GRIP1 VANGL1 DOCK7 ANKRD17 MACF1 CRYBG3 LRBA PEAK1 ENO1 | 5.16e-09 | 708 | 283 | 24 | 39231216 | |
| Pubmed | SMG1 MYCBP2 TOGARAM1 TLK1 DST NRXN1 SRGAP3 BAIAP3 TTC28 SYNE1 CEP72 MACF1 APPL1 NIN | 5.66e-09 | 225 | 283 | 14 | 12168954 | |
| Pubmed | KANSL1L SMG1 MYCBP2 SUCLG2 PARP4 DST MED12L MAP3K7 ARHGAP21 SDCBP HSPG2 IPO7 SYNE1 JMJD1C AKAP12 MYH14 MACF1 APPL1 ENO1 ENO3 | 6.09e-09 | 497 | 283 | 20 | 23414517 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TPR SMG1 CENPF INTS1 ZC3H11A DST SRGAP3 ARHGAP21 KPNA4 DIP2B MYBBP1A IPO7 UBR4 MYO1B PRDX2 ATL1 GRIP1 TARDBP MACF1 ENO2 | 6.30e-09 | 498 | 283 | 20 | 36634849 |
| Pubmed | FSTL5 RAP1GAP2 ZC3H11A SRGAP3 BAIAP3 ARHGAP21 PLXNB3 ACSL6 TTC28 ZSWIM5 SYNE1 ATP9A PCDHB16 EPG5 WDR47 GCC2 DOCK7 MACF1 | 8.42e-09 | 407 | 283 | 18 | 12693553 | |
| Pubmed | An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway. | 6.36e-08 | 6 | 283 | 4 | 17110930 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TBC1D19 MYCBP2 SDCCAG8 COG3 PTK6 TMCO4 TLK1 ZC3H11A PLCB4 BAIAP3 SMURF2 DIP2B TUT4 POLR1A RASA2 RPAIN ANXA6 ANXA7 FBXL17 TEP1 BABAM2 JMJD1C PCDHB16 ANO8 MYH14 GCC2 ANKRD17 MACF1 SCAF11 TANC1 SPIDR LRBA CUX1 HTT | 6.71e-08 | 1489 | 283 | 34 | 28611215 |
| Pubmed | TPR ZNF148 DST SUPT5H ARHGAP21 KPNA4 MYBBP1A DSC1 TTC28 UBR4 MYO1B MUC5B IDH1 RUFY1 SPECC1 BABAM2 RAB34 ARID2 MACF1 SCAF11 ENO1 | 7.14e-08 | 634 | 283 | 21 | 34591612 | |
| Pubmed | 1.42e-07 | 132 | 283 | 10 | 22496890 | ||
| Pubmed | TOGARAM1 PARP4 TLK1 MED12 CLSTN1 JMJD1C ANO8 PIKFYVE CCDC88C CEP72 ARID2 UTP4 MACF1 APPL1 CEP152 SPIDR PEAK1 RAB21 | 1.52e-07 | 493 | 283 | 18 | 15368895 | |
| Pubmed | MPDZ DST ARHGAP21 WWC1 TTC28 DOCK7 MACF1 CEP131 CEP152 TANC1 CRYBG3 PEAK1 | 1.69e-07 | 209 | 283 | 12 | 36779422 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR MYCBP2 CENPF INTS1 ZC3H11A NF1 DST SUPT5H ZBTB21 MYBBP1A POLR1A IPO7 SYNE1 ANXA6 MYO1B SPECC1 TARDBP MYH14 BBS7 VANGL1 UTP4 DOCK7 MACF1 CEP131 RAB21 ENO1 | 3.66e-07 | 1024 | 283 | 26 | 24711643 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | HMGCS1 SUCLG2 TLK1 PLCB4 SDCBP WWC1 CCNL2 JMJD1C TARDBP ARID2 UTP4 KCNK5 SCAF11 CEP152 TANC1 PEAK1 AGAP9 CUX1 | 5.15e-07 | 536 | 283 | 18 | 15840001 |
| Pubmed | 5.33e-07 | 3 | 283 | 3 | 11940661 | ||
| Pubmed | HMGCS1 SUCLG2 TLK1 PLCB4 SDCBP WWC1 CCNL2 JMJD1C TARDBP ARID2 UTP4 KCNK5 SCAF11 CEP152 TANC1 PEAK1 AGAP9 CUX1 | 5.43e-07 | 538 | 283 | 18 | 10512203 | |
| Pubmed | ZNF148 MCC KSR1 ZBTB21 SFXN2 HSD11B1 WWC1 CCNL2 TUT4 HDAC6 TTC28 FAT3 TAF1C ADNP2 LAMB1 TEP1 ARHGEF40 RNH1 KMT5B VANGL1 ARID2 ANKRD17 MACF1 TANC1 CRYBG3 MAP2K7 NIN | 5.51e-07 | 1116 | 283 | 27 | 31753913 | |
| Pubmed | SLC25A46 NDUFV1 NF1 ACSBG1 SRGAP3 ARHGAP21 ACSL6 PRDX2 ATP9A SPECC1 WDR47 GRIP1 TPH2 MACF1 AGAP9 MAP2K1 | 5.88e-07 | 430 | 283 | 16 | 32581705 | |
| Pubmed | TPR ZNF148 MYCBP2 MPDZ ZC3H11A MED12 MYBBP1A TTC28 RUFY1 JMJD1C TARDBP ARID2 DOCK7 LRBA PEAK1 ENO1 CUX1 HTT | 7.26e-07 | 549 | 283 | 18 | 38280479 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYCBP2 PSMB2 FYCO1 COG3 GDI2 DST SFN MYBBP1A SYNE1 UBR4 MYO1B MUC5B IDH1 PRDX2 EPG5 NBAS TARDBP MYH14 MACF1 LRBA PEAK1 ENO1 | 9.46e-07 | 807 | 283 | 22 | 30575818 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPR MYCBP2 ACAT2 MPDZ HMGCS1 GDI2 DST LRRIQ1 EIF2B3 MAP3K7 KPNA4 MYBBP1A IPO7 UBR4 MYO1B IDH1 PRDX2 RFC1 SARNP AKAP12 TARDBP DOCK7 ANKRD17 MACF1 RAB21 ENO1 ENO2 | 9.61e-07 | 1149 | 283 | 27 | 35446349 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DTD1 HGH1 ACAT2 PSMB2 COG3 GDI2 SUPT5H EIF2B3 RABGGTA SFN KPNA4 RAP1GDS1 IPO7 NOL3 ANXA6 UBR4 LAMB1 IDH1 PRDX2 SARNP RUFY1 BABAM2 AKAP12 RNH1 SBNO1 MYH14 MACF1 APPL1 LRBA ENO2 HTT | 1.16e-06 | 1455 | 283 | 31 | 22863883 |
| Pubmed | INTS1 ERLEC1 KSR1 C17orf75 ZMIZ2 ZBTB21 TRIM50 DENND5B GCFC2 HDAC6 IPO8 TAF1C UBR4 ADNP2 ACAD10 PRDX2 AKAP12 CEP131 ENO1 DNAH11 | 1.16e-06 | 689 | 283 | 20 | 36543142 | |
| Pubmed | TPR CENPF HMGCS1 KPNA4 ACSL6 DSC1 ANXA7 UBR4 DOCK7 APPL1 ATOH1 LRBA ENO2 | 1.49e-06 | 304 | 283 | 13 | 32235678 | |
| Pubmed | EPHB2 TPR AUP1 ACAT2 INTS1 HMGCS1 TLK1 ZC3H11A NF1 MED12 KPNA4 DENND5B CCNL2 UBR4 CCDC51 RUFY1 GTPBP10 NBAS RNH1 SBNO1 KMT5B ARID2 ANKRD17 CCDC120 NAA40 MAP2K7 ZNF415 ENO3 HTT | 1.59e-06 | 1327 | 283 | 29 | 32694731 | |
| Pubmed | 1.70e-06 | 100 | 283 | 8 | 10048485 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPR AUP1 PSMB2 SUCLG2 GDI2 SFN IPO8 IPO7 DSC1 UBR4 ABCC11 MYO1B PRDX2 AKAP12 TARDBP RNH1 MYH14 LRBA ENO1 | 1.82e-06 | 647 | 283 | 19 | 26618866 |
| Pubmed | Proteomic characterization of the human centrosome by protein correlation profiling. | 1.97e-06 | 26 | 283 | 5 | 14654843 | |
| Pubmed | ZNF148 CENPF DST ARHGAP21 MED12 SDCBP SRBD1 SARNP ARID2 UTP4 MACF1 CEP131 TANC1 CRYBG3 MAP2K1 CUX1 | 1.98e-06 | 472 | 283 | 16 | 38943005 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SLC25A46 MYCBP2 AUP1 CENPF SUCLG2 GDI2 NDUFV1 SPTBN5 DST EIF2B3 MAP3K7 DIP2B MYBBP1A TUT4 IPO8 TTC28 SYNE1 UBR4 CCDC51 GTPBP10 ATL1 PIKFYVE NBAS AASS VANGL1 ARID2 UTP4 TANC1 CRYBG3 TRIM13 CUX1 | 2.05e-06 | 1496 | 283 | 31 | 32877691 |
| Pubmed | A Moonlighting Human Protein Is Involved in Mitochondrial Import of tRNA. | 2.12e-06 | 4 | 283 | 3 | 25918939 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | ZNF148 MPDZ SDCBP DIP2B SYNE1 MYO1B RFC1 SPECC1 GUCA1B MYH14 ANKRD17 CUX1 NIN | 2.71e-06 | 321 | 283 | 13 | 32098917 |
| Pubmed | TPR RAP1GAP2 TLK1 DST MAP3K7 KPNA4 RAP1GDS1 SYNE1 ANXA7 ADNP2 LAMB1 ARID2 ANKRD17 MACF1 MAP2K1 CUX1 | 2.87e-06 | 486 | 283 | 16 | 20936779 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | ACAT2 GDI2 PARP4 ARHGAP21 SDCBP SFN PRSS12 ANXA7 IDH1 PRDX2 TARDBP ARHGEF40 RNH1 MYH14 LZTS1 DOCK7 ANKRD17 ENO1 CUX1 NIN | 2.89e-06 | 732 | 283 | 20 | 34732716 |
| Pubmed | GALK2 HGH1 ACAT2 HMGCS1 SUCLG2 NDUFV1 EIF2B3 RABGGTA HSPG2 RAP1GDS1 IPO8 IPO7 DSC1 ANXA6 IDH1 AKAP12 TARDBP RNH1 LRBA MAP2K1 ENO1 HTT | 3.70e-06 | 878 | 283 | 22 | 37223481 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PDE8A MYCBP2 SDCCAG8 MCC KSR1 TLK1 SLC9C1 NF1 NRXN1 SUPT5H EIF2B3 ZBTB21 KPNA4 MYBBP1A IPO8 PRDX2 CCDC51 SARNP AKAP12 RNH1 SBNO1 BBS7 GCC2 DOCK7 APPL1 PDE5A CEP131 RAB21 | 4.34e-06 | 1321 | 283 | 28 | 27173435 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | DTD1 PSMB2 FYCO1 GDI2 ZC3H11A SFN KLHL4 REXO5 IPO7 ZSWIM5 PRAMEF13 RNH1 PRAMEF14 UTP4 ANKRD17 ENO1 ENO3 | 4.55e-06 | 564 | 283 | 17 | 21565611 |
| Pubmed | MPDZ KSR1 NF1 DST WWC1 HDAC6 TTC28 GRIP1 CCDC88C CEP72 DOCK7 CEP131 CEP152 MAP2K1 NIN | 4.55e-06 | 446 | 283 | 15 | 24255178 | |
| Pubmed | COG3 SUCLG2 ERLEC1 SPATA2L C17orf75 NF1 ACSBG1 RAPGEF3 SUPT5H BAIAP3 KPNA4 UBR4 AIDA ATL1 CCDC88C ENO1 ZNF415 | 4.99e-06 | 568 | 283 | 17 | 9110174 | |
| Pubmed | A "double adaptor" method for improved shotgun library construction. | COG3 SUCLG2 ERLEC1 SPATA2L C17orf75 NF1 ACSBG1 RAPGEF3 SUPT5H BAIAP3 KPNA4 UBR4 AIDA ATL1 CCDC88C ENO1 ZNF415 | 5.73e-06 | 574 | 283 | 17 | 8619474 |
| Pubmed | AUP1 ZC3H11A DST MAP3K7 ARHGAP21 PLEKHA8 MYBBP1A TTC28 ABCC5 RUFY1 AKAP12 TARDBP VANGL1 GCC2 DOCK7 CEP131 LRBA PEAK1 RAB21 CUX1 | 6.98e-06 | 777 | 283 | 20 | 35844135 | |
| Pubmed | HGH1 MYCBP2 ERLEC1 NDUFV1 DST RAD1 PLCB4 SDCBP KPNA4 IPO7 ANXA7 UBR4 LAMB1 MYO1B RFC1 SARNP SPECC1 BABAM2 AKAP12 TARDBP ARHGEF40 CEP72 VANGL1 MACF1 NAA40 RAB21 MAP2K1 | 8.96e-06 | 1297 | 283 | 27 | 33545068 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ZNF148 ZC3H11A DST ZBTB21 ARHGAP21 SDCBP MYBBP1A DSC1 MYO1B IDH1 PRDX2 RFC1 AKAP12 TARDBP ARID2 UTP4 ANKRD17 MACF1 NAA40 LRBA ENO1 | 9.75e-06 | 934 | 283 | 22 | 33916271 |
| Pubmed | PSMB2 SLFN5 DST RABGGTA SFN KPNA4 LAMB1 IDH1 PRDX2 RFC1 SARNP ANKRD17 MACF1 ENO1 ENO2 ENO3 | 1.03e-05 | 538 | 283 | 16 | 28524877 | |
| Pubmed | 1.05e-05 | 6 | 283 | 3 | 19433310 | ||
| Pubmed | Systematic analysis and nomenclature of mammalian F-box proteins. | 1.05e-05 | 61 | 283 | 6 | 15520277 | |
| Pubmed | MYCBP2 MCC MPDZ ERLEC1 TUT4 GCFC2 POLR1A TTC28 JMJD1C ATL1 PIKFYVE NBAS RNH1 BBS7 VANGL1 CEP131 TANC1 TRIM13 RAB21 | 1.08e-05 | 733 | 283 | 19 | 34672954 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | PDE8A PSMB2 GDI2 C16orf89 PARP4 RAPGEF3 SDCBP SFN HSPG2 TUT4 RAP1GDS1 REXO5 ANXA6 ANXA7 ABCC11 MYO1B IDH1 CUBN RAB34 RNH1 MYH14 APPL1 RAB21 | 1.15e-05 | 1016 | 283 | 23 | 19056867 |
| Pubmed | 1.23e-05 | 94 | 283 | 7 | 25201988 | ||
| Pubmed | TPR PSMB2 HMGCS1 GDI2 MAP3K7 MED12 WWC1 SFN KPNA4 MYBBP1A IPO7 LAMB1 MYO1B IDH1 PRDX2 RFC1 SPECC1 TARDBP RNH1 MYH14 UTP4 ANKRD17 CCDC120 MAP2K1 ENO1 CUX1 | 1.29e-05 | 1247 | 283 | 26 | 27684187 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | MAP3K7 WWC1 KPNA4 DIP2B GRIP1 PIKFYVE RNH1 CEP131 PEAK1 AGAP9 | 1.33e-05 | 218 | 283 | 10 | 33378226 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ERBB3 NF1 DST DIP2B DDR2 ABCC5 AKAP12 RAB34 LZTS1 VANGL1 DOCK7 APPL1 PEAK1 | 1.52e-05 | 377 | 283 | 13 | 38117590 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYCBP2 CENPF FYCO1 ERLEC1 KPNA4 RAP1GDS1 IPO8 IPO7 CCDC51 RNH1 SBNO1 STC2 MYH14 CEP72 AASS GCC2 CEP131 CUX1 NIN | 1.59e-05 | 754 | 283 | 19 | 33060197 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | HGH1 CENPF TOPAZ1 GRID2IP PLCB4 ARHGAP21 MED12 SDCBP KPNA4 POLR1A ANXA7 RUFY1 ARID2 ERCC6L2 LRBA | 1.64e-05 | 497 | 283 | 15 | 36774506 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR AUP1 CENPF PSMB2 GDI2 NDUFV1 ZC3H11A NF1 SUPT5H SDCBP MYBBP1A POLR1A IPO8 IPO7 DSC1 SYNE1 ANXA6 UBR4 MYO1B PRDX2 RFC1 TARDBP SBNO1 MYH14 UTP4 DOCK7 PEAK1 ENO1 | 1.74e-05 | 1425 | 283 | 28 | 30948266 |
| Pubmed | PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. | 1.82e-05 | 7 | 283 | 3 | 9883737 | |
| Pubmed | The GTPase-deficient Rnd proteins are stabilized by their effectors. | 1.82e-05 | 7 | 283 | 3 | 22807448 | |
| Pubmed | SMG1 CENPF ERLEC1 TLK1 RND1 DST NRXN1 ZBTB21 SMURF2 ARHGAP21 SFN KPNA4 MYBBP1A ZSWIM5 SYNE1 UBR4 DNAH2 ABCC5 MYO1B SRBD1 TARDBP RGS14 SBNO1 MYH14 MACF1 RAB21 ENO1 CUX1 | 2.15e-05 | 1442 | 283 | 28 | 35575683 | |
| Pubmed | 2.28e-05 | 142 | 283 | 8 | 30809309 | ||
| Pubmed | TPR MYCBP2 HMGCS1 NDUFV1 NF1 NRXN1 ACSBG1 SRGAP3 MAP3K7 TUT4 UBR4 SH3KBP1 PRDX2 ATL1 ANO8 WDR47 DOCK7 MACF1 APPL1 CEP131 CRYBG3 PEAK1 RAB21 ENO1 | 2.37e-05 | 1139 | 283 | 24 | 36417873 | |
| Pubmed | TPR HGH1 MYCBP2 FYCO1 ERLEC1 RAP1GDS1 RUFY1 RNH1 CEP131 HTT NIN | 2.48e-05 | 285 | 283 | 11 | 32838362 | |
| Pubmed | MYCBP2 ACAT2 DST MAP3K7 MED12 SDCBP TTC28 RFC1 SRBD1 BABAM2 MYH14 CEP72 DOCK7 CEP131 CEP152 LRBA NIN | 2.56e-05 | 645 | 283 | 17 | 25281560 | |
| Pubmed | GALK2 MYCBP2 SUCLG2 MED12 SDCBP DSC1 BABAM2 RNH1 LZTS1 PEAK1 MAP2K1 | 2.73e-05 | 288 | 283 | 11 | 38496616 | |
| Pubmed | 2.78e-05 | 146 | 283 | 8 | 21399614 | ||
| Pubmed | SMG1 ERBB3 MPDZ PARP4 DST SUPT5H RAD54B ARHGAP21 DIP2B TTC28 CLSTN1 JMJD1C ARHGEF40 DOCK7 ANKRD17 TANC1 CRYBG3 | 2.81e-05 | 650 | 283 | 17 | 38777146 | |
| Pubmed | AUP1 UNC5B NF1 RAP1GDS1 ABCC5 MYO1B SPECC1 AKAP12 ATL1 VANGL1 MACF1 PEAK1 RAB21 CUX1 | 3.37e-05 | 467 | 283 | 14 | 30194290 | |
| Pubmed | MEK Is a Key Regulator of Gliogenesis in the Developing Brain. | 4.01e-05 | 24 | 283 | 4 | 22998872 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | DTD1 MPDZ GDI2 NF1 SFN DIP2B MYBBP1A UBR4 ACAD10 KANK4 ENO1 ENO2 ENO3 HTT | 4.05e-05 | 475 | 283 | 14 | 31040226 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.52e-05 | 202 | 283 | 9 | 33005030 | |
| Pubmed | TPR MYCBP2 MYBBP1A POLR1A ARHGEF40 MYH14 DOCK7 SCAF11 MAP2K1 | 4.52e-05 | 202 | 283 | 9 | 24639526 | |
| Pubmed | 4.80e-05 | 116 | 283 | 7 | 30804394 | ||
| Pubmed | 4.90e-05 | 49 | 283 | 5 | 21362503 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | INS MCC FZD4 POLR3D ACSBG1 MAP3K7 WWC1 HDAC6 TAF1C ANXA7 UBR4 SH3KBP1 AIDA RFC1 SARNP JMJD1C DALRD3 AKAP12 CCDC88C CEP70 DOCK7 HMGXB3 TRIM13 | 5.49e-05 | 1124 | 283 | 23 | 21900206 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPHB2 AUP1 PSMB2 HMGCS1 SUCLG2 GDI2 ZC3H11A SUPT5H SFN MYBBP1A RAP1GDS1 HDAC6 IPO8 DSC1 ANXA6 ANXA7 UBR4 MUC5B IDH1 PRDX2 RFC1 AKAP12 TARDBP RAB34 ANKRD17 ENO1 | 6.01e-05 | 1367 | 283 | 26 | 32687490 |
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 6.50e-05 | 27 | 283 | 4 | 23027611 | |
| Pubmed | ARHGAP21 TTC28 JMJD1C VANGL1 MACF1 TANC1 CRYBG3 LRBA PEAK1 TRIM13 | 6.56e-05 | 263 | 283 | 10 | 34702444 | |
| Pubmed | Visual consequences of molecular changes in the guanylate cyclase-activating protein. | 6.60e-05 | 2 | 283 | 2 | 24557353 | |
| Pubmed | Neuronal cell-surface protein neurexin 1 interaction with multi-PDZ domain protein MUPP1. | 6.60e-05 | 2 | 283 | 2 | 25036961 | |
| Pubmed | Identification of differentially expressed proteins during human urinary bladder cancer progression. | 6.60e-05 | 2 | 283 | 2 | 15936593 | |
| Pubmed | 6.60e-05 | 2 | 283 | 2 | 25058152 | ||
| Pubmed | 6.60e-05 | 2 | 283 | 2 | 15169895 | ||
| Pubmed | 6.60e-05 | 2 | 283 | 2 | 11002341 | ||
| Pubmed | 6.60e-05 | 2 | 283 | 2 | 33436154 | ||
| Pubmed | 6.60e-05 | 2 | 283 | 2 | 7514535 | ||
| Pubmed | The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation. | 6.60e-05 | 2 | 283 | 2 | 26105074 | |
| Pubmed | Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. | 6.60e-05 | 2 | 283 | 2 | 19910924 | |
| Pubmed | RNAi-mediated gene suppression in a GCAP1(L151F) cone-rod dystrophy mouse model. | 6.60e-05 | 2 | 283 | 2 | 23472098 | |
| Pubmed | 6.60e-05 | 2 | 283 | 2 | 36122629 | ||
| Pubmed | Mouse models to study GCAP functions in intact photoreceptors. | 6.60e-05 | 2 | 283 | 2 | 12596933 | |
| Pubmed | 6.60e-05 | 2 | 283 | 2 | 26807827 | ||
| Pubmed | 6.60e-05 | 2 | 283 | 2 | 25063878 | ||
| Pubmed | Cep70 regulates microtubule stability by interacting with HDAC6. | 6.60e-05 | 2 | 283 | 2 | 26112604 | |
| Interaction | YWHAE interactions | MYCBP2 ACAT2 INS PSMB2 MCC RAP1GAP2 KSR1 TLK1 NF1 DST SRGAP3 ZBTB21 MAP3K7 NOS2 ARHGAP21 VCAM1 WWC1 SFN RAP1GDS1 HDAC6 IPO8 TTC28 RUFY1 SPECC1 GRIP1 CCDC88C TARDBP GUCA1B AASS GCC2 PAFAH2 DOCK7 ANKRD17 MACF1 APPL1 SCAF11 CEP131 TANC1 LRBA PEAK1 MAP2K1 HTT NIN | 2.25e-08 | 1256 | 275 | 43 | int:YWHAE |
| Interaction | GOLGA1 interactions | COG3 DST TTC28 UBR4 RUFY1 LZTS1 GCC2 MACF1 CEP131 CEP152 TANC1 CRYBG3 PEAK1 TBC1D23 | 2.32e-07 | 183 | 275 | 14 | int:GOLGA1 |
| Interaction | YWHAZ interactions | ERBB3 MYCBP2 INS MCC RAP1GAP2 KSR1 NF1 DST NRXN1 SRGAP3 ZBTB21 NOS2 ARHGAP21 VCAM1 SFN HDAC6 IPO7 DSC1 TTC28 PRDX2 RUFY1 SPECC1 GRIP1 CCDC88C TARDBP KMT5B AASS GCC2 DOCK7 KCNK5 ANKRD17 MACF1 APPL1 SCAF11 CEP131 TANC1 NAA40 PEAK1 MAP2K1 ENO1 HTT NIN | 2.46e-07 | 1319 | 275 | 42 | int:YWHAZ |
| Interaction | AFDN interactions | EPHB2 KSR1 DST NRXN1 ZBTB21 ARHGAP21 VCAM1 HDAC6 SPECC1 CCDC88C LZTS1 VANGL1 GCC2 MACF1 CEP131 CEP152 PEAK1 NIN | 8.21e-07 | 333 | 275 | 18 | int:AFDN |
| Interaction | NR3C1 interactions | DTD1 SMG1 AUP1 PARP4 C17orf75 NF1 HERC6 WDR17 SFN KLHL4 HDAC6 IPO7 RASA2 TTC28 ANXA6 UBR4 DNAH2 RFC1 LMOD2 BABAM2 JMJD1C GRIP1 LZTS1 CEP72 BBS7 AASS GCC2 ARID2 ANKRD17 NAA40 RAB21 CUX1 DNAH11 | 1.46e-06 | 974 | 275 | 33 | int:NR3C1 |
| Interaction | YWHAQ interactions | TPR MYCBP2 INS KSR1 NF1 DST NRXN1 ZBTB21 NOS2 BANK1 ARHGAP21 WWC1 SFN HDAC6 TTC28 RFC1 RUFY1 SPECC1 GRIP1 CCDC88C RNH1 KMT5B AASS DOCK7 ANKRD17 MACF1 APPL1 CEP131 TANC1 NAA40 LRBA PEAK1 MAP2K1 ENO1 HTT | 4.04e-06 | 1118 | 275 | 35 | int:YWHAQ |
| Interaction | C11orf52 interactions | UNC5B MPDZ DST ARHGAP21 DIP2B ABCC5 MYO1B LRRK1 SPECC1 AKAP12 GRIP1 VANGL1 DOCK7 MACF1 TANC1 PEAK1 | 6.35e-06 | 311 | 275 | 16 | int:C11orf52 |
| Interaction | RAC1 interactions | PDE8A AUP1 UNC5B NF1 DST SRGAP3 PLCB4 NOS2 SMURF2 ARHGAP21 SDCBP VCAM1 KPNA4 RAP1GDS1 HDAC6 IPO8 IPO7 ABCC5 SARNP RUFY1 SPECC1 AKAP12 PIKFYVE ARHGEF40 RAB34 VANGL1 DOCK7 MACF1 TANC1 LRBA PEAK1 MAP2K1 HTT | 9.28e-06 | 1063 | 275 | 33 | int:RAC1 |
| Interaction | TMOD1 interactions | ERLEC1 ARHGAP21 FBXL17 MYO1B RGS14 GCC2 MACF1 CEP131 CEP152 NAA40 NIN | 1.37e-05 | 161 | 275 | 11 | int:TMOD1 |
| Interaction | RAB5A interactions | TPR AUP1 INS UNC5B MTSS1 COG3 GDI2 FZD4 DST SDCBP RABGGTA UBR4 SH3KBP1 RUFY1 SPECC1 AKAP12 PIKFYVE CCDC88C VANGL1 MACF1 APPL1 LRBA PEAK1 TRIM13 HTT | 1.42e-05 | 706 | 275 | 25 | int:RAB5A |
| Interaction | LYN interactions | ERBB3 PDE8A UNC5B NF1 DST FCAR BANK1 ARHGAP21 CCNL2 MYBBP1A POLR1A HDAC6 SH3KBP1 ABCC5 MYO1B SPECC1 AKAP12 CCDC88C VANGL1 DOCK7 MACF1 TANC1 RND2 PEAK1 HTT | 1.97e-05 | 720 | 275 | 25 | int:LYN |
| Interaction | LAMTOR1 interactions | SLC25A46 UNC5B FYCO1 RND1 DST SDCBP PLEKHA8 DENND5B DIP2B HDAC6 ABCC5 ATP9A RUFY1 SPECC1 PIKFYVE BBS7 VANGL1 GCC2 APPL1 RND2 CRYBG3 LRBA PEAK1 TBC1D23 HTT | 2.06e-05 | 722 | 275 | 25 | int:LAMTOR1 |
| Interaction | TNIK interactions | EPHB2 TPR MYCBP2 CENPF DST SRGAP3 MAP3K7 ARHGAP21 WWC1 SFN SYNE1 SH3KBP1 LZTS1 DOCK7 MACF1 NAA40 HTT | 2.09e-05 | 381 | 275 | 17 | int:TNIK |
| Interaction | PHF21A interactions | TPR MYCBP2 CENPF DST ZMIZ2 ARHGAP21 TTC28 UBR4 RUFY1 JMJD1C GCC2 DOCK7 CEP131 NAA40 CRYBG3 LRBA | 2.14e-05 | 343 | 275 | 16 | int:PHF21A |
| Interaction | EZR interactions | ERBB3 MCC GDI2 DST MAP3K7 ARHGAP21 VCAM1 DIP2B RAP1GDS1 CASP10 MYO1B AKAP12 VANGL1 DOCK7 FBXO43 MACF1 TANC1 LRBA PEAK1 ENO1 ENO2 | 2.57e-05 | 553 | 275 | 21 | int:EZR |
| Interaction | WHAMMP3 interactions | 3.76e-05 | 119 | 275 | 9 | int:WHAMMP3 | |
| Interaction | RAB35 interactions | EPHB2 AUP1 UNC5B GDI2 DST ARHGAP21 DENND5B DIP2B HDAC6 ABCC5 RUFY1 SPECC1 AKAP12 RGS14 VANGL1 DOCK7 MACF1 TANC1 PEAK1 TRIM13 HTT | 4.30e-05 | 573 | 275 | 21 | int:RAB35 |
| Interaction | ZBTB7B interactions | ZNF148 MPDZ SDCBP CCNL2 DIP2B MYBBP1A SYNE1 SH3KBP1 MYO1B RFC1 SPECC1 GUCA1B MYH14 ANKRD17 CUX1 NIN | 4.68e-05 | 366 | 275 | 16 | int:ZBTB7B |
| Interaction | STX6 interactions | UNC5B RND1 DST ARHGAP21 MYO1B AKAP12 NBAS VANGL1 GCC2 MACF1 APPL1 RND2 CRYBG3 LRBA PEAK1 ENO1 CUX1 HTT | 4.76e-05 | 448 | 275 | 18 | int:STX6 |
| Interaction | CD6 interactions | SDCBP DIP2B REXO5 POLR1A RASA2 TRIM68 SRBD1 ARHGEF40 VANGL1 UTP4 | 5.20e-05 | 154 | 275 | 10 | int:CD6 |
| Interaction | HSP90AB1 interactions | ERBB3 PDE8A HGH1 MYCBP2 CENPF TSSK2 MCC PTK6 LRRIQ1 MAP3K7 NOS2 VCAM1 HDAC6 IPO7 UBR4 DDR2 DNAH2 LRRK1 RUFY1 UNC45B AASS DOCK7 SCAF11 NAA40 PEAK1 MAP2K1 ENO1 MAP2K7 HTT | 5.47e-05 | 960 | 275 | 29 | int:HSP90AB1 |
| Interaction | DCTN1 interactions | TPR MYCBP2 NF1 DST ARHGAP21 WWC1 HDAC6 IPO8 IPO7 RUFY1 SPECC1 CCDC88C CEP72 MACF1 CEP131 NAA40 ENO3 HTT NIN | 5.73e-05 | 497 | 275 | 19 | int:DCTN1 |
| Interaction | PARD3 interactions | UNC5B MPDZ RND1 DST ARHGAP21 SFN KPNA4 MYO1B CCDC88C VANGL1 TANC1 RND2 HTT SMAD7 | 6.49e-05 | 298 | 275 | 14 | int:PARD3 |
| Interaction | KCNA3 interactions | TPR AUP1 UNC5B MPDZ FYCO1 DST ARHGAP21 MED12 MYBBP1A HDAC6 IPO7 TTC28 ABCC5 MYO1B SPECC1 JMJD1C AKAP12 GRIP1 CCDC88C VANGL1 DOCK7 ANKRD17 MACF1 CRYBG3 LRBA PEAK1 ENO1 | 6.50e-05 | 871 | 275 | 27 | int:KCNA3 |
| Interaction | PFN1 interactions | TPR NF1 GRID2IP ARHGAP21 VCAM1 HDAC6 RUFY1 NBAS GCC2 DOCK7 MACF1 CEP131 CEP152 TANC1 NAA40 CRYBG3 PEAK1 ENO1 HTT | 7.85e-05 | 509 | 275 | 19 | int:PFN1 |
| Interaction | PPIA interactions | ZNF148 CENPF INS RND1 DST SUPT5H ARHGAP21 MED12 SDCBP VCAM1 HDAC6 ANXA7 RFC1 SRBD1 SARNP TARDBP ARID2 UTP4 MACF1 CEP131 TANC1 NAA40 RND2 CRYBG3 MAP2K1 ENO1 CUX1 | 8.97e-05 | 888 | 275 | 27 | int:PPIA |
| Interaction | SIRT7 interactions | TPR MYCBP2 CENPF INTS1 GDI2 ZC3H11A NF1 DST SUPT5H MED12 MYBBP1A POLR1A IPO7 ANXA6 UBR4 MYO1B RFC1 RNH1 MYH14 UTP4 DOCK7 ANKRD17 MACF1 SCAF11 | 9.18e-05 | 744 | 275 | 24 | int:SIRT7 |
| Interaction | KDM1A interactions | TPR ZNF148 MYCBP2 CENPF FYCO1 DST SUPT5H SRGAP3 ZBTB21 ARHGAP21 MED12 HDAC6 TTC28 UBR4 RUFY1 JMJD1C LZTS1 GCC2 CEP70 DOCK7 ANKRD17 CEP131 CEP152 CRYBG3 LRBA CUX1 HTT NIN | 9.56e-05 | 941 | 275 | 28 | int:KDM1A |
| Interaction | FLOT1 interactions | PDE8A UNC5B MPDZ NF1 DST ARHGAP21 DIP2B HDAC6 MYO1B AKAP12 VANGL1 MACF1 TANC1 RND2 CRYBG3 PEAK1 HTT NIN | 1.00e-04 | 475 | 275 | 18 | int:FLOT1 |
| Interaction | CFLAR interactions | 1.02e-04 | 79 | 275 | 7 | int:CFLAR | |
| Interaction | CCDC8 interactions | TPR MYCBP2 INTS1 RND1 NF1 DST ZBTB21 MYBBP1A POLR1A IPO7 ANXA6 MYO1B SPECC1 DALRD3 MYH14 BBS7 VANGL1 DOCK7 MACF1 CEP131 RND2 ENO1 | 1.04e-04 | 656 | 275 | 22 | int:CCDC8 |
| Interaction | YWHAH interactions | MYCBP2 MPDZ KSR1 NF1 GRID2IP DST ZBTB21 MAP3K7 ARHGAP21 WWC1 SFN DIP2B TTC28 SPECC1 GRIP1 CCDC88C AASS DOCK7 ANKRD17 MACF1 APPL1 CEP131 CEP152 TANC1 CRYBG3 LRBA PEAK1 RAB21 MAP2K1 HTT NIN | 1.11e-04 | 1102 | 275 | 31 | int:YWHAH |
| Interaction | MYCBP2 interactions | EPHB2 TPR ERBB3 MYCBP2 DST NOS2 ARHGAP21 SFN MYBBP1A UBR4 AKAP12 DOCK7 MACF1 APPL1 ATOH1 | 1.18e-04 | 355 | 275 | 15 | int:MYCBP2 |
| Interaction | ITCH interactions | ERBB3 PDE2A MTSS1 CFLAR KSR1 RND1 MAP3K7 SFN HDAC6 DSC1 LRRK1 RND2 MAP2K1 HTT SMAD7 | 1.21e-04 | 356 | 275 | 15 | int:ITCH |
| Interaction | PCNT interactions | DST ARHGAP21 IPO8 IPO7 SYNE1 CEP72 UTP4 MACF1 CEP131 CEP152 NAA40 NIN | 1.25e-04 | 241 | 275 | 12 | int:PCNT |
| Interaction | SKP1 interactions | MYCBP2 FBXW12 INS PSMB2 MTSS1 CFLAR FBXL2 MAP3K7 NOS2 SFN FOXN2 POLR1A FBXL14 FBXL17 RUFY1 FBXO31 FBXO43 HTT | 1.27e-04 | 484 | 275 | 18 | int:SKP1 |
| Interaction | CTNNB1 interactions | EPHB2 MPDZ NDUFV1 ZC3H11A RND1 DST ZMIZ2 ARHGAP21 SFN MYBBP1A HDAC6 DDR2 ABCC11 MYO1B SPECC1 AKAP12 GRIP1 CCDC88C TARDBP RGS14 MYH14 AASS FBXO31 CCDC120 TANC1 RND2 CUX1 HTT SMAD7 | 1.30e-04 | 1009 | 275 | 29 | int:CTNNB1 |
| Interaction | YWHAB interactions | MYCBP2 MCC KSR1 NF1 GRID2IP DST ZBTB21 ARHGAP21 VCAM1 WWC1 SFN TTC28 SPECC1 GRIP1 CCDC88C RNH1 AASS GCC2 DOCK7 ANKRD17 MACF1 APPL1 CEP131 TANC1 NAA40 PEAK1 MAP2K1 ENO1 HTT | 1.42e-04 | 1014 | 275 | 29 | int:YWHAB |
| Interaction | RHOF interactions | PDE8A AUP1 UNC5B MPDZ PLCB4 ARHGAP21 RAP1GDS1 HDAC6 IPO7 ABCC5 SPECC1 AKAP12 PIKFYVE RAB34 VANGL1 DOCK7 MACF1 TANC1 PEAK1 MAP2K1 ENO1 HTT | 1.50e-04 | 673 | 275 | 22 | int:RHOF |
| Interaction | RAC2 interactions | PDE8A AUP1 INTS1 NDUFV1 DST PLCB4 NOS2 ARHGAP21 SDCBP VCAM1 RAP1GDS1 ABCC5 MYO1B PRDX2 RUFY1 SPECC1 AKAP12 ARHGEF40 VANGL1 MACF1 PEAK1 HTT | 1.53e-04 | 674 | 275 | 22 | int:RAC2 |
| Interaction | DLG4 interactions | PDE2A GDI2 FZD4 NRXN1 ACSL6 DIP2B SYNE1 SH3KBP1 PRDX2 RGS14 VANGL1 MACF1 APPL1 TANC1 PEAK1 ENO1 HTT | 1.58e-04 | 449 | 275 | 17 | int:DLG4 |
| Interaction | CBLB interactions | 1.82e-04 | 115 | 275 | 8 | int:CBLB | |
| Interaction | DSCR9 interactions | 1.92e-04 | 147 | 275 | 9 | int:DSCR9 | |
| Interaction | RAB9A interactions | AUP1 FYCO1 GDI2 DST RABGGTA DDR2 ATP9A RUFY1 SPECC1 ATL1 PIKFYVE NBAS VANGL1 GCC2 RND2 CRYBG3 LRBA PEAK1 TRIM13 HTT | 2.09e-04 | 595 | 275 | 20 | int:RAB9A |
| Interaction | EFNB1 interactions | EPHB2 RND1 NF1 EIF2B3 SMURF2 SDCBP VCAM1 IPO8 IPO7 ACAD10 GRIP1 RND2 | 2.12e-04 | 255 | 275 | 12 | int:EFNB1 |
| Interaction | DYRK1A interactions | TPR ERBB3 MYCBP2 CENPF NF1 SDCBP SFN KPNA4 CCNL2 LAMB1 BABAM2 WDR47 TARDBP LZTS1 CEP70 DOCK7 CEP131 TANC1 LRBA | 2.23e-04 | 552 | 275 | 19 | int:DYRK1A |
| Interaction | LCK interactions | ERBB3 AUP1 PTK6 NF1 DST NOS2 ARHGAP21 DIP2B SH3KBP1 MYO1B VANGL1 GCC2 MACF1 TANC1 CRYBG3 PEAK1 MAP2K7 | 2.27e-04 | 463 | 275 | 17 | int:LCK |
| Interaction | DMPK interactions | 2.29e-04 | 41 | 275 | 5 | int:DMPK | |
| Interaction | GSK3A interactions | MPDZ DST ARHGAP21 WWC1 SFN HDAC6 TTC28 SRBD1 SBNO1 DOCK7 MACF1 CEP131 CEP152 TANC1 CRYBG3 PEAK1 NIN | 2.32e-04 | 464 | 275 | 17 | int:GSK3A |
| Interaction | ERC1 interactions | MAP3K7 RABGGTA SH3KBP1 LRRK1 CEP152 NAA40 TBC1D23 MAP2K7 HTT NIN | 2.58e-04 | 187 | 275 | 10 | int:ERC1 |
| GeneFamily | Armadillo repeat containing|Importins | 3.16e-05 | 18 | 189 | 4 | 596 | |
| GeneFamily | Caspases|Death effector domain containing|Ripoptosome|Death inducing signaling complex | 3.82e-05 | 7 | 189 | 3 | 1019 | |
| GeneFamily | EF-hand domain containing | 5.07e-04 | 219 | 189 | 9 | 863 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.04e-03 | 43 | 189 | 4 | 409 | |
| GeneFamily | F-box and leucine rich repeat proteins | 1.30e-03 | 21 | 189 | 3 | 558 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 1.59e-03 | 6 | 189 | 2 | 1342 | |
| GeneFamily | Phosphodiesterases | 1.94e-03 | 24 | 189 | 3 | 681 | |
| GeneFamily | Mitogen-activated protein kinase kinases | 2.21e-03 | 7 | 189 | 2 | 653 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.92e-03 | 8 | 189 | 2 | 939 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 GALK2 ZNF148 PDE8A MYCBP2 CENPF TOGARAM1 TLK1 DST PLCB4 SMURF2 WWC1 TUT4 IPO7 TTC28 DDR2 MYO1B PIKFYVE NBAS GCC2 ANKRD17 MACF1 CRYBG3 SPIDR RAB21 MAP2K1 CUX1 SMAD7 | 1.75e-07 | 856 | 280 | 28 | M4500 |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN | ERBB3 PDE2A INS CCNL2 DIP2B RASA2 TTC28 TAF1C ANKRD17 TANC1 MAP2K7 SMAD7 NIN | 2.52e-07 | 199 | 280 | 13 | M9031 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR SMG1 ZNF148 MYCBP2 APOBEC3G SLFN5 TLK1 PTPN7 ZC3H11A GVINP1 SRGAP3 SMURF2 KPNA4 FOXN2 TUT4 RAP1GDS1 RASA2 SYNE1 ANXA6 UBR4 SH3KBP1 AIDA JMJD1C EPG5 PIKFYVE CCDC88C RGS14 SBNO1 ARID2 MACF1 SCAF11 LRBA RAB21 MAP2K1 ENO1 SMAD7 NIN | 1.68e-06 | 1492 | 280 | 37 | M40023 |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN | FYCO1 IDNK HSD11B1 HERC6 KLHL4 DIP2B TUT4 RASA2 ANXA6 CCDC88C KMT5B ENO3 | 1.80e-06 | 200 | 280 | 12 | M5059 |
| Coexpression | GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP | PDE2A TOGARAM1 FYCO1 ANKRD16 CCNL2 FOXN2 GCFC2 DHRS11 E4F1 ATP9A RUFY1 | 1.11e-05 | 200 | 280 | 11 | M3419 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | ERBB3 ZNF148 CENPF TOGARAM1 TLK1 DST WWC1 TUT4 PRSS12 PIKFYVE SCAF11 TRIM13 SMAD7 | 2.31e-05 | 300 | 280 | 13 | M8702 |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN | PHLDA3 GDI2 SPTBN5 RAP1GDS1 IPO7 DSC1 ANXA6 AIDA CCDC51 SCAF11 | 5.74e-05 | 198 | 280 | 10 | M7261 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 5.98e-05 | 199 | 280 | 10 | M5893 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 6.24e-05 | 200 | 280 | 10 | M5980 | |
| Coexpression | GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP | PDE2A MTSS1 AS3MT GDI2 C16orf89 ARHGAP21 VCAM1 SYNE1 IDH1 CRYBG3 | 6.24e-05 | 200 | 280 | 10 | M7235 |
| Coexpression | GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN | ACAT2 CENPF RND1 RAPGEF3 BANK1 DALRD3 AKAP12 GUCA1A STC2 RND2 | 6.24e-05 | 200 | 280 | 10 | M7792 |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | MTSS1 UBA7 DST TRIM50 ARHGAP21 DENND5B DIP2B TTC28 CASP10 AIDA | 6.24e-05 | 200 | 280 | 10 | M7978 |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN | MDGA2 COG3 HSD11B1 BAIAP3 SMURF2 KPNA4 DIP2B SPECC1 VANGL1 TBC1D23 | 6.24e-05 | 200 | 280 | 10 | M5679 |
| Coexpression | GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN | 7.67e-05 | 129 | 280 | 8 | M354 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | PDE2A PDE8A UNC5B MTSS1 MDGA2 SLFN5 C16orf89 FZD4 CLCA1 GVINP1 RAPGEF3 PLCB4 SDCBP SH3BP5 KLHL4 DIP2B HSPG2 ANXA6 LAMB1 MYO1B AIDA JMJD1C PCDHB16 ATL1 MACF1 CRYBG3 PEAK1 SMC1B NIN | 1.36e-06 | 831 | 275 | 29 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | SMG1 PDE8A ZNF398 ZSWIM5 TOP6BL SRBD1 CUBN ATL1 PIKFYVE LRBA SMC1B HTT | 6.26e-06 | 187 | 275 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ACAT2 CENPF COG3 ERLEC1 PTPN7 C17orf75 MAP3K7 SMURF2 TUT4 GCFC2 TTC28 NOL3 SH3KBP1 FBXL17 DALRD3 GRIP1 PIKFYVE GCC2 CEP70 DOCK7 ERCC6L2 MACF1 CORIN SCAF11 CUX1 NIN | 1.10e-05 | 780 | 275 | 26 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000 | KANSL1L ERBB3 MYCBP2 SDCCAG8 CFLAR SFXN2 MAP3K7 VCAM1 WWC1 ANKRD16 TUT4 REXO5 HDAC6 ZSWIM5 PRSS12 LAMB1 IGSF11 CUBN BABAM2 TARDBP PAFAH2 PAH ERCC6L2 CUX1 ENTPD8 | 1.96e-05 | 758 | 275 | 25 | gudmap_developingKidney_e15.5_Proximal Tubules_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | ACAT2 CENPF COG3 PTPN7 TUT4 TTC28 GCC2 CEP70 MACF1 CORIN SCAF11 LRBA PEAK1 NIN | 2.87e-05 | 291 | 275 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d106.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | PDE2A RAP1GAP2 ACSBG1 HSD11B1 FBXL2 BAIAP3 TUT4 REXO5 PRSS12 ANXA6 SH3KBP1 CCDC88C KCNK5 MACF1 PEAK1 | 9.60e-05 | 367 | 275 | 15 | GSM538401_500 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.00e-04 | 142 | 275 | 9 | gudmap_kidney_adult_Podocyte_MafB_k2_1000 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDE2A MTSS1 MCC SLFN5 GVINP1 RAPGEF3 PLCB4 DIP2B MYO1B CCDC88C LZTS1 UNC45B TANC1 PEAK1 | 1.14e-11 | 181 | 282 | 14 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TPR SMG1 MYCBP2 MTSS1 SLFN5 TUT4 SH3KBP1 TEP1 AKAP12 GCC2 MACF1 SCAF11 NIN | 1.69e-10 | 182 | 282 | 13 | f8c73baaaca145e2efc48f10f636feb79c8fc779 |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MTSS1 MCC SLFN5 GVINP1 RAPGEF3 PLCB4 DIP2B MYO1B CCDC88C LZTS1 UNC45B TANC1 | 2.15e-09 | 182 | 282 | 12 | 81279877b920b5a1bc991a07d3031d6458700fe3 |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TPR SMG1 MYCBP2 SLFN5 TUT4 SH3KBP1 JMJD1C AKAP12 GCC2 MACF1 SCAF11 NIN | 2.59e-09 | 185 | 282 | 12 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | PDE8A DENND5B DIP2B TTC28 FBXL17 CUBN BABAM2 JMJD1C ANKRD17 MACF1 LRBA CUX1 | 3.95e-09 | 192 | 282 | 12 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TPR SMG1 MYCBP2 SLFN5 TUT4 SH3KBP1 JMJD1C AKAP12 GCC2 MACF1 SCAF11 | 2.80e-08 | 184 | 282 | 11 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | TBC1D19 APOBEC3G SLFN5 CFLAR PTPN7 HERC6 SMURF2 SH3BP5 ANXA6 CCDC88C MACF1 | 4.34e-08 | 192 | 282 | 11 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 |
| ToppCell | (21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | TBC1D19 APOBEC3G SLFN5 CFLAR PTPN7 HERC6 SMURF2 SH3BP5 ANXA6 CCDC88C MACF1 | 4.34e-08 | 192 | 282 | 11 | b0a573ddde2978485a857b8261ee1ee5ef68ecef |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | MYCBP2 CENPF SLFN5 TLK1 ZC3H11A LRRIQ1 SPECC1 SBNO1 GCC2 APPL1 SCAF11 | 5.94e-08 | 198 | 282 | 11 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-07 | 169 | 282 | 10 | d18b823836ca6fba79a2d2f10cb9966fa2623af2 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-07 | 169 | 282 | 10 | befb9b1618ea30fbf8983bcc493853da53b809c3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SMG1 ERBB3 PTK6 KSR1 SRGAP3 ARHGAP21 MUC5B MYH14 MACF1 TANC1 | 2.27e-07 | 179 | 282 | 10 | 6e965e424eebef50f0202cff75f458be395cfca1 |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ERBB3 INS NRXN1 PLXNB3 IGSF11 CLSTN1 PAFAH2 KANK4 KCNK5 ENO2 | 2.65e-07 | 182 | 282 | 10 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-07 | 187 | 282 | 10 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-07 | 193 | 282 | 10 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-07 | 193 | 282 | 10 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-07 | 193 | 282 | 10 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.76e-07 | 194 | 282 | 10 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.76e-07 | 194 | 282 | 10 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.99e-07 | 195 | 282 | 10 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 5.23e-07 | 196 | 282 | 10 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 5.23e-07 | 196 | 282 | 10 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.65e-07 | 155 | 282 | 9 | e1a20e88b9c0eaf7ca7004acc0eda096d1588563 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 178 | 282 | 9 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Heart-RV-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDE2A MCC SLFN5 C16orf89 DENND5B TMEM182 HSPG2 CYP26B1 UNC45B | 2.20e-06 | 179 | 282 | 9 | 6aa211670e5d6e013d0980967aa0a4f8f2905efe |
| ToppCell | facs-Heart-RV-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDE2A MCC SLFN5 C16orf89 DENND5B TMEM182 HSPG2 CYP26B1 UNC45B | 2.20e-06 | 179 | 282 | 9 | cf4d3828a3ce97932c68d06f5c65a070fc6d832c |
| ToppCell | facs-Heart-RV-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDE2A MCC SLFN5 C16orf89 DENND5B TMEM182 HSPG2 CYP26B1 UNC45B | 2.20e-06 | 179 | 282 | 9 | f9bc76ff25f88ee44c72499a0df9dc16f519c4cb |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 C16orf89 GVINP1 HSPG2 CYP26B1 TTC28 MACF1 TANC1 SMAD7 | 2.30e-06 | 180 | 282 | 9 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 C16orf89 GVINP1 HSPG2 CYP26B1 TTC28 MACF1 TANC1 SMAD7 | 2.30e-06 | 180 | 282 | 9 | 423454e3390080ae03bb3cbb267255ebfe4df080 |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-06 | 183 | 282 | 9 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.76e-06 | 184 | 282 | 9 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.76e-06 | 184 | 282 | 9 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SLFN5 C16orf89 FZD4 RAPGEF3 HSPG2 CYP26B1 LAMB1 UNC45B KANK4 | 3.59e-06 | 190 | 282 | 9 | 9d5242759546be0089981ef1877e4ed5f81face5 |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.91e-06 | 192 | 282 | 9 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.91e-06 | 192 | 282 | 9 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.08e-06 | 193 | 282 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-06 | 195 | 282 | 9 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-06 | 195 | 282 | 9 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-06 | 195 | 282 | 9 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 4.43e-06 | 195 | 282 | 9 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | Tuft-tuft-3|World / Class top | 4.76e-06 | 148 | 282 | 8 | f4f59b46a79fc9aa4c5d330a7b37b1a34a6d71cc | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.82e-06 | 197 | 282 | 9 | bb35a2b7320fda92e9cd42f536b7bd54e3a73a32 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.82e-06 | 197 | 282 | 9 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.02e-06 | 198 | 282 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 5.02e-06 | 198 | 282 | 9 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.02e-06 | 198 | 282 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-06 | 199 | 282 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.23e-06 | 199 | 282 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 5.23e-06 | 199 | 282 | 9 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 167 | 282 | 8 | 2184c2760b6142e62124a2454a552723e20d4f61 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 84 | 282 | 6 | 6c8018d65df335c81fe4099a34e0053c8dbcf88d | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 176 | 282 | 8 | 5386386619cf173939d3c117b20e6f27ab397993 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 176 | 282 | 8 | 820edade963768e4bfd86b554da4cd7100567ac8 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-05 | 177 | 282 | 8 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-05 | 178 | 282 | 8 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 179 | 282 | 8 | ba38177ffcf3a20f02afeeaaa91bc8eab8d1ac05 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 179 | 282 | 8 | d121351b4c3b91108e6c5753d18a44d676f38d4c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-05 | 179 | 282 | 8 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-05 | 180 | 282 | 8 | f24d4cbba4cb50fce3b3d9c4629aa856d9b05358 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.99e-05 | 180 | 282 | 8 | e4add4c94f892a2d93926e5c6dac6a738319d091 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 182 | 282 | 8 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 182 | 282 | 8 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 182 | 282 | 8 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 182 | 282 | 8 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 183 | 282 | 8 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 183 | 282 | 8 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 183 | 282 | 8 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 183 | 282 | 8 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 183 | 282 | 8 | 98fee6838acfaee5e2e449ba088764ec06b8bc57 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 133 | 282 | 7 | 81189e8516a431d5890a0909f9fc7c82ec3442bc | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 185 | 282 | 8 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 186 | 282 | 8 | 41f1674afc17661eccaa779cdeb663db5e45685d | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 186 | 282 | 8 | aa006650cf21a2c51dfe1091681f67fdad939107 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-05 | 186 | 282 | 8 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 186 | 282 | 8 | ea936e66ae4b7b40564711fad60ac0137327995f | |
| ToppCell | Club-club-11|World / Class top | 2.51e-05 | 55 | 282 | 5 | d1d832e1c98a89e2b461127922c3e4d7f42d7401 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.61e-05 | 187 | 282 | 8 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 187 | 282 | 8 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.61e-05 | 187 | 282 | 8 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | facs-Heart-LV-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 187 | 282 | 8 | 1bc338c22d645a854f8d8eb8a064c441121fb673 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 188 | 282 | 8 | e5a8ca4613ab0bf1584b9e78959adf41d0bf379f | |
| ToppCell | facs-Heart-LV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 188 | 282 | 8 | 0fc3a6562e6895f6fe7a93397eae842a75c60c93 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.71e-05 | 188 | 282 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 188 | 282 | 8 | ed11e26ff4ef3d6314b5f5734062519b9aa285c1 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 189 | 282 | 8 | d9c2adbbe3e40eb8d57200b6411533e6685ea0d2 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 189 | 282 | 8 | 476226787c8ea0c9834a6f4c99ac7091cc20a455 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.82e-05 | 189 | 282 | 8 | e830fa0ddc3dccfaf9e88e8c416ed6aab12e3e3f | |
| ToppCell | facs-Trachea-nan-18m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 189 | 282 | 8 | 5ced78f4b5c276b1bab24df807c00cf5ac8ed3d4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 189 | 282 | 8 | 3fe69bad6427e41b8d2dae450828cc21e9c3b3ad | |
| ToppCell | facs-Trachea-nan-18m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 189 | 282 | 8 | 2105d8b011b93a460237e00bc029efd7762dc8d5 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.82e-05 | 189 | 282 | 8 | ecbe079606406f47d4fc97fe1670790dda8e10de | |
| ToppCell | facs-Trachea-nan-18m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 189 | 282 | 8 | 100eda87ac9c38dddcfa58408b057867a1738acb | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.82e-05 | 189 | 282 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | facs-Trachea-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.82e-05 | 189 | 282 | 8 | f635f3f13bced3bcf796cf55723a2df851f973fe | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.84e-05 | 138 | 282 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 190 | 282 | 8 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.93e-05 | 190 | 282 | 8 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 190 | 282 | 8 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 190 | 282 | 8 | 65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-05 | 190 | 282 | 8 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| Drug | N-succinylphenylglycine | 1.84e-06 | 3 | 280 | 3 | CID000448582 | |
| Drug | AC1MOUJL | 1.84e-06 | 3 | 280 | 3 | CID003400924 | |
| Drug | C03356 | 1.84e-06 | 3 | 280 | 3 | CID000439988 | |
| Drug | 3-bromo-2-(bromomethyl)propionic acid | 1.84e-06 | 3 | 280 | 3 | CID000318915 | |
| Drug | C04309 | 1.84e-06 | 3 | 280 | 3 | CID000440293 | |
| Drug | 2,3-diketo-1-phosphohexane | 1.84e-06 | 3 | 280 | 3 | CID000192519 | |
| Drug | dimethyl chlorophosphate | 7.29e-06 | 4 | 280 | 3 | CID000101863 | |
| Drug | [2-(oxidoamino)-2-oxoethyl]phosphonic acid | 7.29e-06 | 4 | 280 | 3 | CID011969443 | |
| Drug | 3-aminoenolpyruvate-2-phosphate | 7.29e-06 | 4 | 280 | 3 | CID003037152 | |
| Drug | 2-ptz | 7.29e-06 | 4 | 280 | 3 | CID000445375 | |
| Drug | tricyclohexylammonium | 7.29e-06 | 4 | 280 | 3 | CID000226271 | |
| Drug | Benzethonium chloride [121-54-0]; Up 200; 9uM; MCF7; HT_HG-U133A | TBC1D19 EPHB2 CENPF UNC5B HMGCS1 CFLAR RND1 FCAR MUC5B SLC9A5 SPIDR | 1.51e-05 | 180 | 280 | 11 | 6070_UP |
| Drug | N-methylacrylamide | 1.81e-05 | 5 | 280 | 3 | CID000014471 | |
| Drug | AC1L1CAI | 1.81e-05 | 5 | 280 | 3 | CID000000145 | |
| Drug | tartronate semialdehyde phosphate | 1.81e-05 | 5 | 280 | 3 | CID000151938 | |
| Drug | 2-phospho-3-butenoic acid | 1.81e-05 | 5 | 280 | 3 | CID000191423 | |
| Drug | 1-Pdmsp | 1.81e-05 | 5 | 280 | 3 | CID000000561 | |
| Drug | Chloroprene | TPR MTSS1 MCC TOGARAM1 HMGCS1 COG3 TLK1 UBA7 RND1 CLCA1 NRXN1 TMEM178A PLCB4 SMURF2 BANK1 VCAM1 SFN SH3BP5 TUT4 CYP26B1 ANXA6 DDR2 SH3KBP1 DNAH2 MYO1B IDH1 AKAP12 TARDBP FBXO31 GCC2 ARID2 ERCC6L2 KANK4 PDE5A NAA40 | 2.45e-05 | 1348 | 280 | 35 | ctd:D002737 |
| Drug | Monobenzone [103-16-2]; Down 200; 20uM; HL60; HT_HG-U133A | KANSL1L CENPF MTSS1 RAP1GAP2 KSR1 SPATA2L RAD54B TAF1C MYO1B MAP2K7 ENO2 | 2.74e-05 | 192 | 280 | 11 | 3054_DN |
| Drug | LY294002; Up 200; 10uM; SKMEL5; HG-U133A | MYCBP2 PSMB2 TOGARAM1 PTPN7 ZMIZ2 FBXL2 CASP10 PRDX2 SLC9A5 GUCA1B CUX1 | 2.88e-05 | 193 | 280 | 11 | 501_UP |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; HL60; HT_HG-U133A | KANSL1L KSR1 SPATA2L TLK1 RAD54B BANK1 CASP10 MYO1B VANGL1 KCNK5 HTT | 3.32e-05 | 196 | 280 | 11 | 3029_DN |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; PC3; HT_HG-U133A | APOBEC3G HMGCS1 CLCA1 FCAR ACSBG1 SRGAP3 HSPG2 TUT4 CASP10 SLC9A5 PAFAH2 | 3.47e-05 | 197 | 280 | 11 | 5747_UP |
| Drug | Lidoflazine [3416-26-0]; Up 200; 8.2uM; MCF7; HT_HG-U133A | EPHB2 KANSL1L RAPGEF3 BAIAP3 IPO8 TTC28 CASP10 MUC5B TEP1 SLC9A5 MAP2K7 | 3.47e-05 | 197 | 280 | 11 | 3201_UP |
| Drug | Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; PC3; HT_HG-U133A | KANSL1L PDE2A SPTBN5 NF1 FCAR C8B BAIAP3 KLHL1 HDAC6 STC2 PDE5A | 3.47e-05 | 197 | 280 | 11 | 3801_UP |
| Drug | Famotidine [76824-35-6]; Up 200; 11.8uM; PC3; HT_HG-U133A | INTS1 CLCA1 BAIAP3 DSC1 TAF1C MYO1B LRRK1 PDE5A SPIDR MAP2K7 ENO3 | 3.47e-05 | 197 | 280 | 11 | 6665_UP |
| Drug | dimidium | 3.58e-05 | 6 | 280 | 3 | CID000068207 | |
| Drug | Z(2-Cl)-OSu | 3.58e-05 | 6 | 280 | 3 | CID000580665 | |
| Drug | 4-(N,N-dimethylamino)cinnamoyl-CoA | 3.58e-05 | 6 | 280 | 3 | CID000445461 | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A | CYP2W1 UBA7 ACSBG1 SRGAP3 ZMIZ2 BAIAP3 BANK1 CASP10 MUC5B PAH RND2 | 3.64e-05 | 198 | 280 | 11 | 3624_UP |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A | PIWIL1 CFLAR RND1 NF1 ZMIZ2 BAIAP3 CYP26B1 MUC5B ARHGEF40 SLC9A5 RND2 | 3.64e-05 | 198 | 280 | 11 | 2228_UP |
| Drug | SB 203580; Down 200; 1uM; PC3; HT_HG-U133A | EPHB2 CENPF ZMIZ2 HERC6 DENND5B GCFC2 TEP1 BABAM2 BBS7 HMGXB3 SPIDR | 3.64e-05 | 198 | 280 | 11 | 7066_DN |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; HL60; HT_HG-U133A | EPHB2 RAP1GAP2 APOBEC3G CYP2W1 SPTBN5 TLK1 FCAR TAF1C CCDC88C ZNF415 ENO3 | 3.64e-05 | 198 | 280 | 11 | 3012_DN |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A | EPHB2 PHLDA3 SRGAP3 ZMIZ2 TUT4 IPO8 TAF1C RGS14 AASS PAFAH2 PDE5A | 3.81e-05 | 199 | 280 | 11 | 4313_DN |
| Drug | Tetrandrine [518-34-3]; Up 200; 6.4uM; HL60; HT_HG-U133A | HMGCS1 RND1 FCAR ZMIZ2 RAD54B HERC6 CYP26B1 HDAC6 MYO1B GUCA1B MYH14 | 3.99e-05 | 200 | 280 | 11 | 2520_UP |
| Drug | Nicotine | TPR GALK2 INS UNC5B HMGCS1 PARP4 RAPGEF3 RAD1 HSD11B1 NOS2 VCAM1 CCNL2 ACSL6 TUT4 SYNE1 SH3KBP1 LAMB1 ATP9A CLSTN1 GUCA1A STC2 TPH2 SCAF11 ATOH1 MAP2K1 ENO1 MAP2K7 NIN | 4.66e-05 | 1000 | 280 | 28 | ctd:D009538 |
| Drug | guanidinium | TPR GALK2 HSD11B1 NOS2 BABAM2 ATL1 TARDBP GUCA1B ENO1 ENO2 ENO3 HTT | 5.55e-05 | 245 | 280 | 12 | CID000003520 |
| Drug | N-tert-butylacrylamide | 6.21e-05 | 7 | 280 | 3 | CID000007877 | |
| Drug | glycidol phosphate | 6.21e-05 | 7 | 280 | 3 | CID000152659 | |
| Drug | lavendustin C6 | 6.21e-05 | 7 | 280 | 3 | CID000126839 | |
| Drug | CPEP | 6.21e-05 | 7 | 280 | 3 | CID000360637 | |
| Drug | vardenafil | 8.57e-05 | 37 | 280 | 5 | CID000110634 | |
| Drug | macrophomate | 9.84e-05 | 8 | 280 | 3 | CID010889109 | |
| Drug | RP 73401 | 1.11e-04 | 39 | 280 | 5 | CID000154575 | |
| Drug | rifampicin | DTD1 TPR GALK2 CYP2W1 POLR3D NOS2 SDCBP CYP26B1 POLR1A PRDX2 PAH ENO2 HTT | 1.16e-04 | 306 | 280 | 13 | CID005381226 |
| Drug | Methamphetamine | PDE2A PDE8A MCC IDNK ZC3H11A DST RAPGEF3 SUPT5H ZMIZ2 MAP3K7 BAIAP3 NOS2 ANKRD16 KPNA4 CCNL2 ACSL6 HSPG2 HDAC6 SYNE1 TAF1C UBR4 PRDX2 CUBN CCDC51 GTPBP10 STC2 CEP72 TPH2 MACF1 MAP2K1 ENO1 MAP2K7 ENO2 CUX1 | 1.21e-04 | 1401 | 280 | 34 | ctd:D008694 |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.40e-04 | 192 | 280 | 10 | 3729_DN | |
| Drug | Eli | 1.42e-04 | 41 | 280 | 5 | CID009549220 | |
| Drug | N-hexacosanol | 1.46e-04 | 9 | 280 | 3 | CID000068171 | |
| Drug | AC1L19IJ | 1.46e-04 | 9 | 280 | 3 | CID000000562 | |
| Drug | AC1L1A4W | 1.46e-04 | 9 | 280 | 3 | CID000000837 | |
| Drug | dinervonylphosphatidylcholine | 1.51e-04 | 2 | 280 | 2 | CID005313741 | |
| Drug | Hyaluronic Acid | 1.52e-04 | 194 | 280 | 10 | ctd:D006820 | |
| Drug | Homocysteine | GDI2 NOS2 VCAM1 IPO7 SH3KBP1 MYO1B JMJD1C CCDC88C PDE5A SCAF11 | 1.59e-04 | 195 | 280 | 10 | ctd:D006710 |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 280 | 10 | 3941_DN | |
| Drug | Nitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A | TBC1D19 MTSS1 ACSBG1 IPO8 SYNE1 CASP10 TRIM68 AASS PAFAH2 MAP2K7 | 1.66e-04 | 196 | 280 | 10 | 6504_UP |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A | EPHB2 MCC APOBEC3G ZMIZ2 BAIAP3 HSPG2 LRRK1 CINP AASS HMGXB3 | 1.66e-04 | 196 | 280 | 10 | 4560_DN |
| Drug | H-89, Dihydrochloride; Down 200; 0.5uM; PC3; HT_HG-U133A | HMGCS1 CFLAR HERC6 DENND5B ABCC5 MUC5B SLC9A5 PAFAH2 KCNK5 ENO1 | 1.66e-04 | 196 | 280 | 10 | 6873_DN |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | CFLAR SPATA2L NF1 SH3BP5 TAF1C CASP10 TRIM68 PRDX2 CCDC88C VANGL1 | 1.66e-04 | 196 | 280 | 10 | 1182_DN |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | EPHB2 CFLAR NF1 ZMIZ2 TAF1C ACAD10 TOP6BL TEP1 PAFAH2 MAP2K7 | 1.73e-04 | 197 | 280 | 10 | 6940_UP |
| Drug | Methiazole; Down 200; 15uM; PC3; HT_HG-U133A | 1.73e-04 | 197 | 280 | 10 | 4532_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.73e-04 | 197 | 280 | 10 | 6796_UP | |
| Drug | clozapine; Down 200; 10uM; HL60; HT_HG-U133A | 1.73e-04 | 197 | 280 | 10 | 2689_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | RAP1GAP2 TLK1 PLCB4 HERC6 SYNE1 CASP10 PRDX2 RGS14 CEP72 CEP131 | 1.73e-04 | 197 | 280 | 10 | 2171_DN |
| Drug | (+,-)-Synephrine [94-07-5]; Down 200; 24uM; PC3; HT_HG-U133A | TBC1D19 MTSS1 MPDZ TOGARAM1 POLR3D REXO5 DHRS11 TAF1C BABAM2 CEP131 | 1.73e-04 | 197 | 280 | 10 | 7150_DN |
| Drug | Luteolin [491-70-3]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.73e-04 | 197 | 280 | 10 | 5004_UP | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; HL60; HG-U133A | 1.73e-04 | 197 | 280 | 10 | 1604_DN | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.73e-04 | 197 | 280 | 10 | 4088_UP | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | KANSL1L PDE2A UBA7 ACSBG1 ZMIZ2 BAIAP3 HDAC6 PRSS12 LRRK1 ARHGEF40 | 1.80e-04 | 198 | 280 | 10 | 3721_UP |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.80e-04 | 198 | 280 | 10 | 2878_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; HL60; HT_HG-U133A | CFLAR DHRS11 TAF1C PRDX2 BABAM2 RGS14 KCNK5 MACF1 CEP152 MAP2K7 | 1.80e-04 | 198 | 280 | 10 | 2356_DN |
| Drug | DO 897/99; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.80e-04 | 198 | 280 | 10 | 7462_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; HL60; HT_HG-U133A | MTSS1 MCC RAP1GAP2 APOBEC3G SPATA2L CLCA1 ZMIZ2 RAD54B FBXL2 BANK1 | 1.80e-04 | 198 | 280 | 10 | 2554_UP |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; HL60; HT_HG-U133A | EPHB2 BANK1 DENND5B NOL3 PRSS12 DALRD3 PAFAH2 MACF1 SPIDR CUX1 | 1.80e-04 | 198 | 280 | 10 | 2714_DN |
| Drug | Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; HL60; HT_HG-U133A | 1.80e-04 | 198 | 280 | 10 | 1268_UP | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; PC3; HT_HG-U133A | PDE2A MTSS1 APOBEC3G RS1 NF1 BAIAP3 KLHL4 FOXN2 RGS14 MAP2K7 | 1.80e-04 | 198 | 280 | 10 | 4102_UP |
| Drug | Procarbazine hydrochloride [366-70-1]; Up 200; 15.6uM; HL60; HT_HG-U133A | EPHB2 APOBEC3G NOL3 SYNE1 PRDX2 ARHGEF40 MYH14 ENO2 ENO3 SMAD7 | 1.80e-04 | 198 | 280 | 10 | 2971_UP |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; HL60; HT_HG-U133A | 1.80e-04 | 198 | 280 | 10 | 1841_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | EPHB2 CFLAR TLK1 CLCA1 FCAR ACSBG1 ZMIZ2 CYP26B1 RGS14 KCNK5 | 1.80e-04 | 198 | 280 | 10 | 3223_UP |
| Disease | Malignant neoplasm of breast | ERBB3 PDE2A CENPF COG3 ZC3H11A NF1 SRGAP3 HSD11B1 NOS2 MED12 PLEKHA8 ZSWIM5 SYNE1 UBR4 CUBN RUFY1 AKAP12 EPG5 SBNO1 STC2 UNC45B MACF1 APPL1 LRBA ENO1 MAP2K7 CUX1 | 1.64e-06 | 1074 | 265 | 27 | C0006142 |
| Disease | melanoma | NF1 PLCB4 HDAC6 DSC1 RASA2 UBR4 CASP10 MYO1B PRDX2 CUBN MAP2K1 CUX1 | 2.84e-06 | 248 | 265 | 12 | C0025202 |
| Disease | alcohol consumption measurement | DTD1 TOPAZ1 SDCCAG8 MDGA2 SUCLG2 SPTBN5 NF1 NRXN1 MAP3K7 BANK1 WWC1 TMEM182 FOXN2 RASA2 DDR2 DNAH2 IGSF11 RFC1 BABAM2 GRIP1 NBAS ARID2 PAFAH2 SCAF11 PEAK1 CUX1 HTT | 2.27e-05 | 1242 | 265 | 27 | EFO_0007878 |
| Disease | cortical thickness | ERBB3 GALK2 PDE8A MYCBP2 AS3MT LRRIQ1 SRGAP3 MAP3K7 BANK1 ARHGAP21 DIP2B HSPG2 PRSS12 FAT3 RUFY1 SPECC1 JMJD1C PCDHB16 GRIP1 ARHGEF40 UTP4 DOCK7 MACF1 ATOH1 | 7.47e-05 | 1113 | 265 | 24 | EFO_0004840 |
| Disease | Autistic Disorder | 1.36e-04 | 261 | 265 | 10 | C0004352 | |
| Disease | Intellectual Disability | SDCCAG8 MCC NF1 NRXN1 SRGAP3 MED12L SYNE1 ATL1 BBS7 AASS MACF1 TBC1D23 HTT | 2.25e-04 | 447 | 265 | 13 | C3714756 |
| Disease | Hydrocephalus | 2.40e-04 | 3 | 265 | 2 | cv:C0020255 | |
| Disease | Congenital hydrocephalus | 2.40e-04 | 3 | 265 | 2 | cv:C0020256 | |
| Disease | C-X-C motif chemokine 11 measurement | 2.42e-04 | 14 | 265 | 3 | EFO_0008057 | |
| Disease | response to xenobiotic stimulus | 2.54e-04 | 182 | 265 | 8 | GO_0009410 | |
| Disease | attention function measurement | 3.97e-04 | 148 | 265 | 7 | EFO_0007636 | |
| Disease | age at menopause | PIWIL1 AS3MT TLK1 MED12 IPO7 TTC28 RPAIN FBXL17 BABAM2 GRIP1 | 4.36e-04 | 302 | 265 | 10 | EFO_0004704 |
| Disease | mean corpuscular hemoglobin concentration | SUCLG2 ACSBG1 DEDD2 SFXN2 ARHGAP21 CYP26B1 POLR1A TTC28 FBXL17 ABCC5 CASP10 MYO1B ACAD10 RFC1 SPECC1 TRIM10 BBS7 KCNK5 MACF1 MAP2K7 ENO2 SMAD7 | 4.48e-04 | 1105 | 265 | 22 | EFO_0004528 |
| Disease | migraine with aura, age at onset | 4.76e-04 | 4 | 265 | 2 | EFO_0004847, MONDO_0005475 | |
| Disease | Mental Depression | 5.17e-04 | 254 | 265 | 9 | C0011570 | |
| Disease | Obesity | 5.61e-04 | 205 | 265 | 8 | C0028754 | |
| Disease | age at onset, smoking initiation | 6.24e-04 | 19 | 265 | 3 | EFO_0004847, EFO_0005670 | |
| Disease | Esophageal Neoplasms | 6.96e-04 | 78 | 265 | 5 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 6.96e-04 | 78 | 265 | 5 | C0546837 | |
| Disease | Cerebellar Ataxia | 7.89e-04 | 5 | 265 | 2 | C0007758 | |
| Disease | LYMPHOMA, NON-HODGKIN, FAMILIAL | 7.89e-04 | 5 | 265 | 2 | 605027 | |
| Disease | whole-brain volume | 7.89e-04 | 5 | 265 | 2 | EFO_0005089 | |
| Disease | Lymphoma, non-Hodgkin, familial | 7.89e-04 | 5 | 265 | 2 | cv:C4721532 | |
| Disease | Non-Hodgkin lymphoma | 7.89e-04 | 5 | 265 | 2 | cv:C0024305 | |
| Disease | systemising measurement | 8.45e-04 | 21 | 265 | 3 | EFO_0010221 | |
| Disease | Immunologic Deficiency Syndromes | 1.11e-03 | 23 | 265 | 3 | C0021051 | |
| Disease | childhood onset asthma, age at onset, environmental tobacco smoke exposure measurement | 1.18e-03 | 6 | 265 | 2 | EFO_0004847, EFO_0008361, MONDO_0005405 | |
| Disease | hydrocephalus (is_implicated_in) | 1.18e-03 | 6 | 265 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | Cystic kidney | 1.18e-03 | 6 | 265 | 2 | C0022679 | |
| Disease | gamma-enolase measurement | 1.18e-03 | 6 | 265 | 2 | EFO_0021845 | |
| Disease | Lissencephaly | 1.18e-03 | 6 | 265 | 2 | C0266463 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | ERBB3 SDCCAG8 AS3MT NRXN1 BANK1 DENND5B TMEM182 FAT3 FBXL17 IGSF11 | 1.23e-03 | 346 | 265 | 10 | EFO_0004337, EFO_0004784, MONDO_0005090 |
| Disease | Noonan Syndrome | 1.26e-03 | 24 | 265 | 3 | C0028326 | |
| Disease | beta-citrylglutamate measurement | 1.64e-03 | 7 | 265 | 2 | EFO_0800060 | |
| Disease | juvenile myelomonocytic leukemia (is_implicated_in) | 1.64e-03 | 7 | 265 | 2 | DOID:0050458 (is_implicated_in) | |
| Disease | Retinal Diseases | 1.79e-03 | 27 | 265 | 3 | C0035309 | |
| Disease | Colorectal Carcinoma | FSTL5 MCC HTR3C FZD4 NF1 FBXL2 SYNE1 ABCC5 MYO1B IDH1 CUBN CINP AKAP12 CUX1 SMAD7 | 1.84e-03 | 702 | 265 | 15 | C0009402 |
| Disease | cholesterol to total lipids in IDL percentage | 2.09e-03 | 60 | 265 | 4 | EFO_0022233 | |
| Disease | Subarachnoid Hemorrhage, Spontaneous | 2.17e-03 | 8 | 265 | 2 | C0472383 | |
| Disease | Subarachnoid Hemorrhage, Intracranial | 2.17e-03 | 8 | 265 | 2 | C0795688 | |
| Disease | Perinatal Subarachnoid Hemorrhage | 2.17e-03 | 8 | 265 | 2 | C0270192 | |
| Disease | Subarachnoid Hemorrhage, Aneurysmal | 2.17e-03 | 8 | 265 | 2 | C0751530 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.17e-03 | 8 | 265 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Psychotic Disorders | 2.21e-03 | 101 | 265 | 5 | C0033975 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.21e-03 | 101 | 265 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.42e-03 | 150 | 265 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | response to angiotensin receptor blocker | 2.43e-03 | 30 | 265 | 3 | EFO_0010735 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.58e-03 | 152 | 265 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.65e-03 | 64 | 265 | 4 | DOID:4947 (is_marker_for) | |
| Disease | Todd Paralysis | 2.77e-03 | 9 | 265 | 2 | C0234544 | |
| Disease | Paralysed | 2.77e-03 | 9 | 265 | 2 | C0522224 | |
| Disease | Colon Carcinoma | 2.77e-03 | 9 | 265 | 2 | C0699790 | |
| Disease | dihydroorotate measurement | 2.77e-03 | 9 | 265 | 2 | EFO_0800647 | |
| Disease | Oxidative Phosphorylation Deficiencies | 2.77e-03 | 9 | 265 | 2 | C0949856 | |
| Disease | Mitochondrial Respiratory Chain Deficiencies | 2.77e-03 | 9 | 265 | 2 | C0949857 | |
| Disease | Electron Transport Chain Deficiencies, Mitochondrial | 2.77e-03 | 9 | 265 | 2 | C0949855 | |
| Disease | Subarachnoid Hemorrhage | 2.77e-03 | 9 | 265 | 2 | C0038525 | |
| Disease | Dupuytren Contracture | 2.96e-03 | 108 | 265 | 5 | EFO_0004229 | |
| Disease | Mammary Carcinoma, Human | ERBB3 PDE2A CENPF ZC3H11A NOS2 MED12 ZSWIM5 SYNE1 AKAP12 STC2 ENO1 MAP2K7 | 3.01e-03 | 525 | 265 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | ERBB3 PDE2A CENPF ZC3H11A NOS2 MED12 ZSWIM5 SYNE1 AKAP12 STC2 ENO1 MAP2K7 | 3.01e-03 | 525 | 265 | 12 | C1257931 |
| Disease | Mammary Neoplasms | ERBB3 PDE2A CENPF ZC3H11A NOS2 MED12 ZSWIM5 SYNE1 AKAP12 STC2 ENO1 MAP2K7 | 3.10e-03 | 527 | 265 | 12 | C1458155 |
| Disease | Disorder of eye | 3.17e-03 | 212 | 265 | 7 | C0015397 | |
| Disease | schizophrenia (implicated_via_orthology) | 3.30e-03 | 68 | 265 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | ulcerative colitis | 3.47e-03 | 335 | 265 | 9 | EFO_0000729 | |
| Disease | triacylglycerol 58:10 measurement | 3.49e-03 | 34 | 265 | 3 | EFO_0010437 | |
| Disease | amino acid measurement | EPHB2 CNTNAP3 C16orf89 MAP3K7 GCFC2 SYNE1 LAMB1 LRRK1 ODAD2 NBAS FBXO31 APPL1 LRBA HTT | 3.51e-03 | 678 | 265 | 14 | EFO_0005134 |
| Disease | platelet component distribution width | SDCCAG8 MTSS1 TLK1 RAPGEF3 EIF2B3 ANKDD1B SYNE1 ABCC5 PRDX2 CUBN JMJD1C GCC2 DOCK7 MACF1 CUX1 | 3.65e-03 | 755 | 265 | 15 | EFO_0007984 |
| Disease | Breast Carcinoma | ERBB3 PDE2A CENPF ZC3H11A NOS2 MED12 ZSWIM5 SYNE1 AKAP12 STC2 ENO1 MAP2K7 | 3.66e-03 | 538 | 265 | 12 | C0678222 |
| Disease | retinal detachment, retinal break | 3.79e-03 | 35 | 265 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | reading and spelling ability | 3.98e-03 | 166 | 265 | 6 | EFO_0005301 | |
| Disease | Malignant neoplasm of prostate | EPHB2 ERBB3 CENPF INS MAP3K7 MED12 MYBBP1A HDAC6 IDH1 PRDX2 MYH14 LZTS1 ARID2 | 4.04e-03 | 616 | 265 | 13 | C0376358 |
| Disease | stomach cancer (is_implicated_in) | 4.06e-03 | 72 | 265 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Primary ciliary dyskinesia | 4.11e-03 | 36 | 265 | 3 | cv:C0008780 | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 4.19e-03 | 11 | 265 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | Cystic Kidney Diseases | 4.19e-03 | 11 | 265 | 2 | C1691228 | |
| Disease | urate measurement, bone density | FSTL5 MCC RAP1GAP2 TTC28 SYNE1 AKAP12 ATL1 LZTS1 PAFAH2 TPH2 CEP70 PEAK1 DNAH11 | 4.20e-03 | 619 | 265 | 13 | EFO_0003923, EFO_0004531 |
| Disease | eosinophil count | ERBB3 PDE8A RAP1GAP2 KPNA7 SLC9C1 SUPT5H MED12L ZNF398 NOS2 VCAM1 DIP2B TMEM182 RASA2 ABCC5 ACAD10 ATP9A CLSTN1 RGS14 RNH1 SPIDR PEAK1 IL5 CUX1 SMAD7 | 4.22e-03 | 1488 | 265 | 24 | EFO_0004842 |
| Disease | free cholesterol to total lipids in large LDL percentage | 4.47e-03 | 74 | 265 | 4 | EFO_0022280 | |
| Disease | colorectal cancer (is_implicated_in) | 4.80e-03 | 121 | 265 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Depressive disorder | 4.81e-03 | 289 | 265 | 8 | C0011581 | |
| Disease | Leukemia, Myelocytic, Acute | 4.86e-03 | 173 | 265 | 6 | C0023467 | |
| Disease | biological sex | 4.94e-03 | 230 | 265 | 7 | PATO_0000047 | |
| Disease | ADHD symptom measurement | 5.00e-03 | 12 | 265 | 2 | EFO_0007860 | |
| Disease | outer ear morphology trait | 5.00e-03 | 12 | 265 | 2 | EFO_0007664 | |
| Disease | phenylacetate measurement | 5.00e-03 | 12 | 265 | 2 | EFO_0021012 | |
| Disease | personality trait | 5.16e-03 | 39 | 265 | 3 | EFO_0004365 | |
| Disease | testosterone measurement | PDE2A PDE8A PSMB2 AS3MT NF1 NRXN1 ANKDD1B BANK1 ARHGAP21 MED12 SDCBP DIP2B POLR1A TTC28 DNAH2 JMJD1C RGS14 ARHGEF40 CEP70 MACF1 MAP2K7 | 5.78e-03 | 1275 | 265 | 21 | EFO_0004908 |
| Disease | homostachydrine measurement | 5.87e-03 | 13 | 265 | 2 | EFO_0021164 | |
| Disease | Cutaneous Melanoma | 5.94e-03 | 41 | 265 | 3 | C0151779 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 6.10e-03 | 301 | 265 | 8 | DOID:684 (is_marker_for) | |
| Disease | high grade glioma (is_implicated_in) | 6.35e-03 | 42 | 265 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | autistic disorder (is_implicated_in) | 6.35e-03 | 42 | 265 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | Maturity onset diabetes mellitus in young | 6.81e-03 | 14 | 265 | 2 | C0342276 | |
| Disease | Pulmonary Fibrosis - from Asbestos Exposure | 6.81e-03 | 14 | 265 | 2 | C2930617 | |
| Disease | multiple myeloma, monoclonal gammopathy | 6.81e-03 | 14 | 265 | 2 | EFO_0000203, EFO_0001378 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 6.81e-03 | 14 | 265 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Manganese Poisoning | 6.81e-03 | 14 | 265 | 2 | C0677050 | |
| Disease | Asbestosis | 6.81e-03 | 14 | 265 | 2 | C0003949 | |
| Disease | insomnia measurement | PDE2A MYCBP2 CYP2W1 UBA7 MED12L BANK1 ARHGAP21 FBXL17 MAP2K1 DNAH11 | 7.10e-03 | 443 | 265 | 10 | EFO_0007876 |
| Disease | reticulocyte measurement | ERLEC1 ACSBG1 BAIAP3 ARHGAP21 MED12 FOXN2 RASA2 MYO1B RFC1 SPECC1 JMJD1C TRIM10 PIKFYVE SLC9A5 RNH1 PDE5A CUX1 SMAD7 | 7.18e-03 | 1053 | 265 | 18 | EFO_0010700 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTNGLRDGIVFVLKC | 471 | Q8TAA9 | |
| GCLTDGQEELILLQE | 671 | Q8NDB2 | |
| ICKILDTADENGLLS | 466 | Q96DZ1 | |
| LQDCLGQTLVLIGKT | 626 | P21860 | |
| SCIEILGQVFISGIK | 1696 | Q9HCE0 | |
| EIQNEKKRGGILCID | 231 | Q8IWZ6 | |
| LICLQQILQDDGKEG | 1316 | O94986 | |
| QGCLRLITIGDKAVD | 511 | Q9BZ76 | |
| EERSDVCLVQLLGTG | 156 | Q6UX73 | |
| ACRKGNVVLEQLLTG | 676 | Q5VTM2 | |
| GCEIDLKEQGQLLHR | 1261 | Q8TER5 | |
| ACTRKNLGVIQELVE | 111 | Q6P6B7 | |
| GQKCVLEEGEKVLNR | 2346 | Q68DQ2 | |
| ELQGVCDTVLGLLDS | 91 | P31947 | |
| LQCSKGRDGIIADIK | 436 | O60239 | |
| SLVEACRKLNEVIGL | 301 | O94812 | |
| ITCLEKGLAEVQQDG | 576 | Q02952 | |
| ICQRIFGEKVLGLSQ | 961 | P39880 | |
| CQEGLRTLAEAGAKI | 321 | Q9HC16 | |
| CTLGIEQLIREVGQI | 1406 | Q7Z2Y8 | |
| GGILQEDISEACLIL | 76 | Q9UDR5 | |
| NEEELTGCILRKLDG | 156 | Q8NB90 | |
| EILGNLCKAEDNGVL | 376 | Q68CP9 | |
| KILQELKCLSGQLDG | 146 | Q8TAV3 | |
| GKIIELEQKCTGILE | 461 | Q5M775 | |
| LEQKCTGILEQGRFE | 466 | Q5M775 | |
| LIQGDGCKIHNLVEE | 876 | Q96DT5 | |
| QAGTIVEARLKELAC | 4441 | Q96DT5 | |
| VLRGINDCDLTQLGI | 511 | Q6JQN1 | |
| ECVGINKLTVLAENL | 106 | Q8WXA8 | |
| IRIEKIGLKDAGQCI | 171 | Q96BJ3 | |
| QGAGTQERVLIEILC | 271 | P20073 | |
| GLQTSVKRLCGEIVE | 556 | Q9P209 | |
| CKEGLDLQVLEDSGR | 561 | O94985 | |
| EVVGGQLTECELELL | 31 | Q8WXF8 | |
| LACSGGRQEVVELLL | 1156 | O75179 | |
| CALEIIKGGALRQEE | 241 | P28845 | |
| LGICLIIDCIGNETE | 251 | O15519 | |
| IADLVVGLCTGQIKT | 381 | P09104 | |
| GILVDIGLDSCKELL | 21 | Q6IQ32 | |
| SGIGTDEKCLIEILA | 106 | P08133 | |
| LGCFQLQELVLSVKG | 376 | Q9HCE9 | |
| CIGRLEVGTETIIDK | 86 | Q01581 | |
| ILVNSRGEIKLCDFG | 196 | Q02750 | |
| TVLAELRKCGLTDNE | 461 | Q9HC84 | |
| RQISKQGLCGAVVDL | 781 | Q9Y620 | |
| LGNEICLCIVGNKID | 121 | Q9UL25 | |
| CVGEVSVNGKRLDLT | 4076 | P98160 | |
| IVVGDLSVGKTCLIN | 56 | Q9BZG1 | |
| ELKLNELITENGTVC | 156 | Q15283 | |
| LVLVGNKCDLVTTAG | 146 | Q7Z444 | |
| LFLEEGGVVTVCKIN | 121 | O60671 | |
| ALEGSLQKRGIVEQC | 81 | P01308 | |
| IGCQQLKARGEVDIL | 306 | P35236 | |
| LKARGEVDILGIVCQ | 311 | P35236 | |
| INLEELTLDGNCISK | 931 | Q6ZRR7 | |
| DGLLDCVKVLVQSGA | 221 | Q8N9V6 | |
| ATILVELSCEDGQGL | 751 | P35228 | |
| CDQITKDGIEALVRG | 166 | Q9UKC9 | |
| GNERSLADCIKQDIG | 571 | P56730 | |
| IGVKSEGEIARCKQL | 266 | P50395 | |
| EKENLCLLIEELGGI | 446 | A9QM74 | |
| IRASKGIVVLEECQL | 406 | A0AUZ9 | |
| VLKSGQLEDTCLVEL | 186 | Q14667 | |
| VLTCLKGQDEQREGL | 1471 | Q86YW9 | |
| LEGALRTKGLELEVC | 436 | Q9Y250 | |
| DRIEGVLCGAVKQLK | 136 | Q8N201 | |
| LEECLGGAQISLAEV | 756 | Q8IX03 | |
| CKSLEGQEGLRQLIF | 806 | Q38SD2 | |
| LKVDDSNTRILIGCL | 391 | Q16832 | |
| GICDLLTQTENRLIG | 3651 | Q03001 | |
| GESLQGCLEEALVLI | 96 | Q5MY95 | |
| TVKELQTCLQGLELG | 311 | Q9BQS8 | |
| QTCLQGLELGAAEKE | 316 | Q9BQS8 | |
| VGILKGVQCEVQLVE | 11 | A0A0C4DH36 | |
| GLEKAIREKLQCTQG | 246 | Q9NR63 | |
| NDKIELLVGCIAELS | 221 | Q4FZB7 | |
| DCLKLAEAGETGRII | 1341 | Q15652 | |
| LNKLETEGTLRICAV | 2051 | Q2LD37 | |
| EGEKICDSVGLAKQI | 611 | Q9UKG1 | |
| ESQKLLEKERLGECG | 76 | Q6P5Q4 | |
| SLVLEESGLKCGELE | 486 | Q9P219 | |
| QELRKVCLQEAELTG | 51 | Q96HB5 | |
| RLLQEGTCKLDEIGS | 991 | Q12766 | |
| IDISCVKIEQVIGAG | 616 | P29323 | |
| GNRLTVDEQEKSIIC | 106 | Q6X9E4 | |
| GVCENLRKLEITGVS | 116 | Q5XUX0 | |
| LDGSVKIQCQAIREA | 41 | P24071 | |
| LVLDQLRCNGVLEGI | 711 | Q7Z406 | |
| LVQLESLETGVGDQC | 1291 | Q9ULL4 | |
| LLEVIILQCKGRGID | 741 | O95373 | |
| CLGQEGLDKILEVVS | 51 | O95279 | |
| CGQLQKLIDISIGSL | 41 | Q8IVT5 | |
| QIKLCDFGISGRLVD | 256 | O14733 | |
| EKECSALGGLFQTII | 6 | O43312 | |
| NLQLSCKVIGDKVLG | 271 | O00408 | |
| SERILISDAKGILQC | 1651 | Q9H792 | |
| GDQCSRLLELVKDIS | 146 | O76074 | |
| DLLDTINSCIRIGKE | 271 | O60658 | |
| VLGRNLSKVELAEIC | 161 | Q01415 | |
| LVERIDGLVSQIDCG | 281 | Q8IVU3 | |
| NLLLVAGGTVLKICD | 161 | O43318 | |
| LEFCGQIILLENGKI | 696 | Q96J66 | |
| ELCTKGLGNQVEVLK | 1256 | Q9P265 | |
| QVCTEVGLVEKVLGK | 126 | P50851 | |
| LIAGQCRCKLNVEGE | 421 | P07942 | |
| LTCLKGQDEQREGLL | 1486 | Q93074 | |
| LLQERTGKLTCAVGD | 771 | O75110 | |
| EEGIDVGTLLKSTCN | 146 | Q96JA3 | |
| LDAGRVKLTVNLDCI | 771 | Q9ULB1 | |
| GIQSLGVKGRECLLD | 1611 | Q9UKK3 | |
| NIGQCVRITDKGLEL | 336 | Q8N1E6 | |
| LIQAVGCLEEFGVKI | 1216 | A2RRP1 | |
| NCGSGDILLKIVKVE | 356 | Q9HAS0 | |
| RKLGCEVLGVSVDSQ | 66 | P32119 | |
| VGGRDGLKTLNTVEC | 481 | Q9C0H6 | |
| NGLNVSIECKRVSGL | 51 | Q86UY6 | |
| KILADSINSEIGILC | 431 | P00439 | |
| VEGVENCGLLQILKL | 1006 | Q96JM4 | |
| REGDTIELQCQVTGK | 456 | Q7Z553 | |
| KEAQTLCDELSVLIG | 4746 | Q9UPN3 | |
| LLGDIQTCIRKSLGE | 616 | Q9BQG0 | |
| LDGRLNKLNCEITEV | 821 | Q8N475 | |
| RNILVGENTLCKVGD | 316 | Q13882 | |
| GLSGKCTLLLQVVDV | 326 | Q9NRJ7 | |
| DGEKIAVLQCILAGL | 471 | Q4G163 | |
| IDLEIQEGKLVGICG | 581 | O15440 | |
| IEVRDGETLLGKVCG | 766 | O60494 | |
| VHGQGCVQIILKELD | 1286 | Q9Y2I7 | |
| VLIQEGLKNTGCAII | 291 | Q9ULV1 | |
| GICVLLGISLEDTQK | 26 | Q8TEA8 | |
| IKDCLIGSGQRIEAK | 421 | Q9NR50 | |
| IADLVVGLCTGQIKT | 381 | P06733 | |
| ELQRVLTGLENVVCG | 161 | P23508 | |
| ATLQDIGKCVEEILG | 1281 | P42858 | |
| NILGGTVFREAIICK | 101 | O75874 | |
| IQGSQDIGSDVILLC | 151 | Q5DX21 | |
| QLCTEEIFQGIGTLE | 61 | P05113 | |
| RDILTQGKDGVALKC | 91 | Q5T6J7 | |
| FDEVVSQGLLGKLCR | 206 | A4D2P6 | |
| AVTGEGIEELKNCIR | 326 | A4D1E9 | |
| DIKEINGNKITCRGL | 311 | Q8WXF7 | |
| LEKVLQQGDIGECAE | 346 | Q96N67 | |
| KVGLDATNCLRITDL | 26 | Q9NXR7 | |
| EKLILLQRCEETGNA | 1021 | P49454 | |
| LVSTVGKLCRLINED | 521 | Q8NHQ1 | |
| KIIEERDIDLSCGNG | 236 | P16383 | |
| EKEVLSNRCIQEVGL | 246 | Q6ZNG2 | |
| DLRVVGCELIQAAGI | 76 | Q96S94 | |
| ETLSELCGILKNEVL | 421 | Q96JB2 | |
| LTDEGLKQLGSKCRE | 451 | Q9UF56 | |
| AEVVGLTELKLGCVL | 4006 | Q8TDW7 | |
| EQGCVIEKLKSELAG | 396 | Q8IWJ2 | |
| AIKLQLVEAGLVECL | 256 | P52306 | |
| LKGGVVVDELGCSRQ | 131 | Q92858 | |
| EKERGSLTVLLCGEN | 1111 | Q6ZUT9 | |
| KLVNQDAEGIGEICL | 506 | Q96GR2 | |
| ITIQNKELERVIGDC | 236 | Q9HBK9 | |
| SKERCESVLGIVGLQ | 536 | Q9Y5Q5 | |
| VDGNGCIDRDELLTI | 101 | P43080 | |
| LQAETLVGKVNLEEC | 41 | Q08554 | |
| TRSKEEIAEILCNIG | 771 | Q8N7U6 | |
| LLNTSIEQGILECEK | 246 | P32314 | |
| GLLTRESCDKGIEVN | 421 | Q5T7N3 | |
| INGKQCGDKIELLIL | 191 | Q8IYD9 | |
| LGVQDVENLKFLCIG | 31 | Q92851 | |
| GILGRLCLKELVEEQ | 211 | Q5D0E6 | |
| LCLKELVEEQGRTAG | 216 | Q5D0E6 | |
| IADLVVGLCTGQIKT | 381 | P13929 | |
| TKGGCLLEVEELLVS | 596 | Q66K89 | |
| QGSCLTKDILEREGQ | 701 | Q5T890 | |
| VTEGQKLILLCSVAG | 216 | Q96LA5 | |
| KEQLIQEGLLDRCVS | 116 | Q9UBN7 | |
| SILKQCGQEAALLIE | 221 | Q9Y3R0 | |
| EDLETCGQSGILREL | 896 | Q9Y3R0 | |
| AGILKGVQCEVQLVE | 11 | A0A0C4DH30 | |
| LKVVGCARTVGNIEE | 36 | Q6UWP2 | |
| EKCLIGVDLGTQENI | 2931 | Q9P225 | |
| GIREVILCKDQDGKI | 111 | O00560 | |
| CLESEISENILEKGG | 506 | Q99590 | |
| LAREEIKNGKCVVIG | 616 | A3KN83 | |
| KLQERCSELKGQLGE | 946 | Q9UPN4 | |
| LGVSVGKCRGILNEI | 396 | P07358 | |
| QGCLRLITIGDKAVD | 511 | Q96NU0 | |
| KIAASLETLILEGCQ | 346 | Q5VWM6 | |
| CRQQAGLLVTGEKEE | 401 | O14830 | |
| ECLRVLKILQEVTAG | 191 | Q99487 | |
| DVRTACEKLIQVLIG | 326 | Q9BTY7 | |
| LLEVIILQCKGRGID | 741 | O15397 | |
| GIIILKDNVAREGCI | 216 | Q5VVY1 | |
| DRGQELVDGLKVCLQ | 666 | Q96J94 | |
| LLVGCEDGSVKLFQI | 116 | Q969X6 | |
| GVCKESVNRQGKIEL | 166 | F8VTS6 | |
| CTLADLTEGQVGKLL | 316 | P05423 | |
| CEGVNLIGKNRKEVE | 291 | P19320 | |
| LGNLILSVKCEEAEG | 176 | Q684P5 | |
| QVIIREGELLCGVLD | 736 | O95602 | |
| IKGICVKDRNENEIG | 201 | Q96NB2 | |
| ECEILGEVLAQLGTS | 161 | Q8IUW3 | |
| RSEGKEGQVLECSLI | 51 | Q15147 | |
| ELTEQKLRACLEGSI | 166 | Q86UA6 | |
| LSGEIIGEINCLTNE | 946 | Q4G0N8 | |
| KDCQGIIEDVILLGA | 421 | Q5TGY1 | |
| CDIDVSKGALLEGQL | 21 | Q8N6T0 | |
| CGEVERIQNLLGTKQ | 1956 | Q8NF91 | |
| QSLCGEDLIIKGISV | 241 | Q13148 | |
| LKQECLARGLETKGI | 16 | P82979 | |
| KLQEVCEDLGITRDG | 186 | Q8N4C6 | |
| CLEGLREQLDGLEKT | 316 | Q96ER9 | |
| KIAASLETLILEGCQ | 346 | Q5SWL7 | |
| KGAENCLEGLIFVIT | 401 | P35251 | |
| VARCKLVLVGDVQCG | 11 | Q92730 | |
| DIDTLILKGIAQRCT | 126 | Q8NBL3 | |
| QLTCALKEGDVTIGE | 31 | Q86SQ7 | |
| LGAEASCQKGERVLL | 426 | Q15572 | |
| CGEETALIESIEGKQ | 206 | P49821 | |
| CQLAIRDVGGLEVLI | 486 | Q5T2S8 | |
| DVQKECVLLKGRQEG | 326 | Q92696 | |
| LCLKGEDLDSQVGVI | 266 | Q96T51 | |
| NGCIDRLELLNIVEG | 106 | Q9UMX6 | |
| CKGLLANTLVEDVNI | 761 | Q96Q15 | |
| GDIVTLINKDCIDVG | 291 | Q96B97 | |
| KILLLCVGEAGDTVQ | 41 | P49721 | |
| EVLQEGKVSGSLEVC | 731 | Q14940 | |
| LLERGCDVNLSDKQG | 1131 | Q9C0D5 | |
| IQLEKELANLGGVCA | 2156 | O75592 | |
| LLLLVQGKGEAACQE | 61 | O60936 | |
| IRGNELELAVCVGTV | 981 | Q8IZU2 | |
| VEVCEGELINLQGKI | 426 | O00267 | |
| VCLEDLQIGTVLTGK | 911 | Q8N5C6 | |
| GDVLVCVQKGEKENR | 91 | P50120 | |
| LIQALDCGKDLESVQ | 2386 | Q9NRC6 | |
| CVLTERGLQLFEAKG | 31 | Q9Y5J5 | |
| NVELVETLLKAGCDL | 346 | A6NHY2 | |
| EEALKERGQKCGVVI | 231 | Q9UKU0 | |
| LCEELQATLDGLTKI | 91 | Q9BW66 | |
| QIGQRIVCLVLDKSG | 301 | A8K7I4 | |
| IQRDLAKTGCVDLTI | 316 | Q9Y679 | |
| AQELKCVLGILILSG | 176 | Q6P3X8 | |
| ELELIICGLGKIDVN | 621 | Q9HAU4 | |
| DGNDRLKLVVLLCGE | 801 | Q8IWX7 | |
| VVVGDAECGKTALLQ | 11 | P52198 | |
| QVVGICQVLLDEGAL | 151 | O95398 | |
| NILLVDGTACGEIKI | 591 | Q9UKI8 | |
| TESEVLLGIDLLCGN | 221 | O94967 | |
| IIANGITKACRELEL | 371 | Q96I99 | |
| KIGCGIQLTREVDGV | 316 | O15105 | |
| KGQLCDVLLIVGDQK | 26 | Q9ULJ3 | |
| VQTLQKQCILLLEGG | 706 | Q9P217 | |
| GLGVCKQNVDRKEVV | 371 | Q6AZZ1 | |
| KKCLEGILEGSVRNS | 31 | O60858 | |
| AEQVDVVLCGGDTLK | 716 | Q99973 | |
| GRIAIGDCILSINEE | 1046 | O75970 | |
| LKAVCLAVQSIGIGD | 96 | Q9BWD1 | |
| DLLKQTLGEGERAEC | 461 | O43295 | |
| GQRVLVLELSCEGDD | 986 | P41226 | |
| RDNTGILECVKEGIG | 231 | Q96AG3 | |
| LDCKVQDIEIILLSG | 931 | Q8NDV3 | |
| EVKSVLGKEVGLLNC | 871 | Q14159 | |
| LGREKGNEILELKCN | 211 | P12270 | |
| SLDGILVDGICIKVQ | 561 | Q96IC2 | |
| NLLLTCGEEVKEAIT | 176 | O76061 | |
| CEKTVTELGNQLEGK | 81 | Q8TD17 | |
| QGECLNFGIKTLEEI | 206 | O75152 | |
| LEAGGCDLETLRNII | 26 | Q9NUY8 | |
| LKIEGQLLETSGLCI | 1886 | P21359 | |
| DINEAGVRVLCQGLK | 181 | P13489 | |
| GKRQTCDIEGLVELL | 491 | O43566 | |
| LTCKICVRQVEGEGQ | 806 | Q8IZJ1 | |
| TIEFGLCKQEGQLRA | 361 | Q8IWU9 | |
| VCNKTALLEGLEVDQ | 641 | Q8NF64 | |
| VECLQSLGKESIIEG | 151 | Q8N9V7 | |
| LCEVGQEEVILKTGK | 1906 | Q96AY4 | |
| GITDLSRNCVIKELA | 91 | Q09FC8 | |
| QLVSTLGLGEEDVCQ | 86 | Q9UDY6 | |
| VCKAVIQGKQLEGLV | 11 | P63123 | |
| NRCAIKGGLLTSEED | 286 | Q9UQR1 | |
| EGGSDEKRLCLQLLS | 146 | Q9Y4F4 | |
| KVISGILTQGRCDID | 131 | O15537 | |
| CQISGQAKIDILLVG | 11 | Q9NX45 | |
| CILLGETTEKINAER | 746 | Q5TAX3 | |
| SLQELGGSEKLLRVC | 246 | Q5T4S7 | |
| AGLCTGDRIIKVNGE | 116 | Q5T5U3 | |
| ELKECFVELGLNIGQ | 196 | Q8N5T2 | |
| LLELSKGNTVVQCGL | 306 | Q86XT4 | |
| LLATEVGRCSGEKNI | 31 | Q6ZP80 | |
| ELGVQGDLLEFIKCQ | 91 | Q96PF2 | |
| AVDLGLQEKQGVICD | 426 | Q08AF3 | |
| LQEKQGVICDALLIS | 431 | Q08AF3 | |
| GQGSEREELKALSCL | 146 | Q8WUU4 | |
| LLIKGVGICEDRNST | 166 | A8MPX8 | |
| NLIEECGGLEKIEQL | 451 | O00629 | |
| IGGRDGLKTLNTVEC | 511 | Q9NR64 | |
| LKEICELTGIDQSVL | 306 | O43795 |